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The field of neurobiology focuses on the development, maintenance, and function of the
nervous system. Of particular interest is the formation of synapses, the junctions which
allow for transmission and control of information between neurons. Synapse formation
can be broken into two general processes: structural formation and activity-dependent
validation. Structural formation requires transmembrane adhesion proteins that connect
the two sides of the synapse. This newly- formed connection is then validated through
neurotransmitter-mediated activity, which is deciphered by receptors on the postsynaptic
side.
In order to compare the role of two adhesion molecules (NL1 and SynCAM) and two gluta-
mate receptors (NMDAR and AMPAR) on synaptogenesis, heterologous synapse systems
were created between neurons and HEK cells expressing various combinations of these
proteins (NL1 alone; SynCAM alone; NL1/NMDAR; NL1/AMPAR; SynCAM/NMDAR;
SynCAM/AMPAR). These heterologous synapses were then stained for synapsin, and the
size of the presynaptic contact (determined by the area of synapsin staining) was compared
between the experimental groups. Results show that receptor expression causes the forma-
iii
tion of smaller contacts than when the adhesion molecule is expressed on its own. These
results suggest a role for the glutamate receptors in refining synaptic contacts during the
process of synaptic validation.
Keywords: Synaptogenesis, Synapse Validation, Neuroligin-1, SynCAM, AMPAR, NM-
DAR, Heterologous Synapse Systems.
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1.0 INTRODUCTION
In order to survive, organisms must be able to receive, process, and transmit information.
The field of neuroscience centers on the study of the nervous system, which is the organ
system that performs this necessary task. Gaining an understanding of how the Central
Nervous System receives information from the periphery and the environment, processes
this information to produce thoughts, emotions, and goal-directed behaviors, and transmits
commands to the periphery, remains an active area of research. Current studies on the ner-
vous system include molecular and cellular questions examining what genes are expressed
in neurons and how they perform their specific task, systems and computational analysis
studying how information processing occurs, and cognitive and behavioral neuroscience
looking at how nervous system function affects thoughts and behavior.
In the subfield of cellular and molecular neuroscience, an active area of research is the
study of synapses, the connections between individual neurons. Since a typical neuron in
the Central Nervous System forms tens of thousands of these contacts, it is important to
understand how new connections are created. This process is called synaptogenesis. In
particular, understanding the role of individual molecular components can help shed light
on how the process of synapse formation occurs during normal development, and how this
process is altered in developmental diseases like autism and epilepsy that are known to
arise due to improper synapse formation. Current techniques to study the role of specific
proteins in synaptogenesis typically use knockouts or (if the protein of interest is a receptor
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or ion channel) pharmacological inhibition. These experimental approaches have inherent
drawbacks. For example, knockouts for key proteins involved in synaptogenesis are often
lethal. Furthermore, both techniques have the possibility of producing results that are
confounded by compensatory mechanisms, since in the nervous system there are several
proteins that have similar (but not redundant) function.
In order to gain an understanding of the role of specific neuronal proteins during synapto-
genesis without the risk of genetic compensation, a simplified system is required. Just as
our understanding of the complexities of the brain have been drastically furthered through
the use of simplified in vitro neuronal culture systems, our understanding of the molecular
synaptic dynamics can be furthered through the use of a simplified heterologous system.
This system involves expressing only the neuronal proteins of interest (e.g cell adhesion
molecules like NL1 and SynCAM, or glutamate receptors like NMDAR and AMPAR) in a
non-neuronal cell. When these non-neuronal cells are cocultured with neurons, heterolo-
gous synapses form, and can be analyzed. Since non-neuronal cells do not express neuronal
proteins, and do not usually form synapses with neurons, they can act as an experimental
”blank-slate” that allows for the construction of protein systems of interest using cellular
and molecular techniques. This project utilizes this approach to study the specific effects
of two cell adhesion molecules, NL1 and SynCAM, and two glutamate receptors, AMPAR
and NMDAR, on synaptogenesis
The thesis is organized into seven chapters. Chapter 1 is this Introduction. Chapter 2 will
provide Background on neurobiology that is well established, and is relevant for under-
standing the project. Chapter 3 will provide some of the Theory behind synaptogenesis.
Chapter 4 provides the Specific Aims, while Chapters 5 discusses the Materials and Meth-
ods used. Chapter 6 provides the Results, and Chapter 7 focuses on a Discussion of these
results and also provides Future Directions.
2
2.0 BACKGROUND
2.1 NEUROBIOLOGY
2.1.1 Neurons and Synapses: Morphology and Physiology
2.1.1.1 Neurons- Cell Morphology and Physiology The majority of information
processing and exchange is performed by neurons in the Central Nervous System. Neurons
are the specialized cells that are designed to receive and transmit information through-
out the body. While these cells vary tremendously in size and shape depending on their
specific location and function, they share common characteristics. Neurons generally have
three anatomic parts with specialized roles. The soma, or cell body, contains the nucleus
and other necessary organelles. Extending off of the the soma are two different types of
membranous processes. Dendrites are specialized processes that receive signals from other
cells and transmits them to soma. Axons allow the forward propagation of summed infor-
mation to other neurons in an all-or-nothing signal called the action potential (AP). Axons
are typically wrapped in an insulating sheath called myelin, and split at the distal end to
form connections called synapses with other neurons. The portion of the axon where the
synapse is located is called the terminal bouton. Synapses typically form between axons
and dendrites, but axo-somatic and axo-axonal synapses are also possible. An image of a
typical neuron is shown in Figure 1 [31, 32].
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Figure 1: A figure of a typical neuron, with the soma, dendrites, myelinated axon, and
terminal boutons labeled. Neurons are the cells that transmit information throughout the
body.
Neurons propagate signals within the cell through changes in membrane potential (the
voltage difference between the inside and outside of the cell), and transmit signals between
cells via a chemical exchange at synapses. The AP is the electrical signal that is used
to send information down the axon. These signals serve as the neural ”code” through
which the nervous system receives and transmits information throughout the body. Action
potentials originate at a region called the axon hillock, at the beginning of the axon.
They then propagate towards the end of the axon, where the signal reaches the synapse
[32, 36].
In addition to the AP signal, neurons also use smaller electrical signals, particular at the
dendrites. Neurons maintain a resting potential of around -70 mV by using ion pumps
to create and sustain concentration gradients across the membrane, with high extracellu-
lar sodium and high intracellular potassium. Additionally, calcium ions, while present at
significantly lower quantities than sodium or potassium, have a higher extracellular than
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intracellular concentration. Neurons can change their membrane potential through the
opening of selectively permeable ion channels. The changes in ion permeability that result
from channel opening, coupled with the established concentration gradients, results in ion
flow either into or out of the neuron. Sodium ion influx results in a depolarizaiton, or posi-
tive change in the membrane potential; potassium ion efflux results in a hyperpolarization,
or negative change in the membrane potential. Using this mechanism of ion flow, neurons
can create electrical signals. The influx of calcium ions can also trigger biochemical cas-
cades that alter the cell’s protein expression and localization, since calcium is an important
second messenger molecule [32, 36].
2.1.1.2 Synapses: Neuron-to-Neuron Connections Synapses play a crucial role
in synthesizing, integrating, and transmitting information through the nervous system.
Information is transmitted in a unidrectional manner from the membrane at the presynapse
to the membrane at the postsynapse. The transformation from electrical signal at the axon
to a chemical signal occurs via an action potential-dependent release of a chemical called
neurotransmitter (NT). The released NT diffuses from the presynapse to ligand-gated ion
channels on the postsynapse, opening these channels and causing current to flow through
them [32, 36].
Synapses come in two general categories, excitatory and inhibitory. Excitatory synapses
cause a depolarization in the membrane potential. Inhibitory synapses cause a hyperpo-
larization in the membrane potential. The difference is based on the specific NT released
by the presynaptic neuron and the receptors that are expressed on the postsynaptic neu-
ron. For example, glutamate is the ubiquitous excitatory NT, while GABA is a common
inhibitory NT. This project focuses on glutamatergic, excitatory synapses. Individual neu-
rons have anywhere from one to hundreds of thousands of synaptic inputs, and the postsy-
naptic neuron integrates these inputs, both excitatory and inhibitory, to decide whether or
not to fire an AP depending on whether or not the membrane potential reaches threshold.
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In this way, synapses integrate convergent inputs, a crucial function of the nervous system.
A figure showing the structure of a synapse is shown in Figure 2 [32, 36].
The specifc proteins involved in synaptic transmission that were examined in this project
will be described in more detail in subsequent sections. At the presynapse, these include
the proteins synapsin, synaptotagmin, and VAMP; at the postsynapse, these include NL
and SynCAM, as well as AMPAR and NMDAR.
2.1.2 Structure of the Postsynapse
The structure of synapses allows for the efficient receipt of chemical signals and transduction
of these signals into electrical impulses. The postsynapse is a highly specialized cellular
structure that consists of ligand-gated ion channels, scaffolding proteins, and adhesion
proteins, which help form protein complexes.This section will provide an overview of the
postsynaptic structure; a description of the specific postsynaptic proteins studied in this
project will be covered in the following subsections.
Identifying specific presynaptic and postsynaptic constituents, as well as understanding
their individual roles in different developmental time points and in normal and diseased
states, are critical to comprehending how synapses develop and function. As previously
mentioned, synapses that release glutamate are the primary excitatory connections in the
human nervous system. At these synapses are two principle families of ligand-gated ion
channels: the alpha- amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor (AMPAR)
and the N-methyl-D- aspartate receptor (NMDAR). NMDARs are ubiquitously found
throughout the brain, while AMPARs are much more variable, and are often missing in
some excitatory glutamatergic synapses. Both NMDAR and AMPAR distribution can be
varied depending on the activity of the neuron [49].
Structural studies of synapses have shown an electron-dense thickening of the plasma mem-
brane of the postsynaptic cell. This is termed the postsynaptic density (PSD) and contains
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Figure 2: A diagram of a typical synapse, which is the connection between the end of an
axon (the presynapse) and the dendrite (the postsynapse). The axon terminal, synaptic
cleft, and dendrite are labeled. Neurotransmitter vesicles and receptors are also shown. At
a synapse, once an action potential arrives at the presynaptic terminal, the depolarization
leads to a calcium influx that triggers the exocytosis of neurotransmitter from the vesicles
into the synaptic cleft. The neurotransmitter then bind to receptors on the dendrite, which
produce graded potentials at the postsynaptic neuron which allow for the continuation of
signal propagation.
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the various postsynaptic proteins. Along with receptors, there are scaffolding proteins (e.g.
Stargazin and PSD-95) that often contain specific amino acid sequences (called PDZ do-
mains) that bind to other proteins (e.g. AMPAR and NMDAR). This interaction results
in the formation of complexes that group the channels, scaffolding proteins, and other key
molecules in a tight cluster so that ion flow through the channels can mediate changes
at the synapse [45]. For example, through the formation of these complexes, glutamate
receptors can transduce presynaptic NT into a signal that affects downstream signal trans-
duction, cytoskeletal anchoring of postsynaptic proteins, and receptor trafficking [49]. The
NMDAR forms several of these complexes. One specific example involves the scaffolding
protein PSD-95, a protein that appears to play a role in synaptic targeting and clustering
of the NMDAR during synaptic validation. The AMPAR also form receptor complexes at
the synapse by binding to the PDZ domains of Stargazin, which then binds to PSD-95.
Just like for NMDARs, experimental evidence also suggests that these clusters play a role
in the synaptic targeting of the receptors [45].
The two sides of the synapse are linked to one another by adhesion proteins. Two exam-
ples that are commonly found at glutamatergic synapses include Neuroligin-1 (NL1) and
SynCAM [29].
It is important to emphasize when talking about postsynaptic structure that the postsy-
naptic density is not static, but dynamically regulated on many levels. Recent studies have
shown that rapid, short-term changes in postsynaptic molecular composition can occur
due to different stimuli, and longer-term changes in the postsynapse are often thought to
be implicated in learning and memory. This regulation of the postsynapse can be either
long-term potentiation (LTP) or long- term depression (LTD). Current evidence indicates
that the AMPAR subunit GluR1 plays a critical role for LTP. This subunit appears to
undergo phosphorylation by multiple postsynaptic proteins, including CaMKII and PKC,
and this phosphorylation potentiates receptor function [45]. In addition to this mechanism,
LTP can occur simply by increasing the number of glutamate receptors at synapses. One
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example of this process is the so-called ”unsilencing” of ”silent synapses.” Silent synapses
have NMDARs but no AMPARs, and as such are ”silent” because the NMDARs have a
voltage-dependent magnesium block that prevents ion flow through the channel. Strong
experimental evidence has shown that these synapses are ”unsilenced” through the recruit-
ment of AMPARs to the synapse- the AMPAR then allows ion flow that depolarizes the
membrane, removing the magnesium block [26]. The potentiation of synapses through
AMPAR subunit phosphorylation and AMPAR recruitment emphasize how very specific
changes to postsynaptic proteins can alter nervous system function.
2.1.2.1 Postsynaptic Adhesion Molecules: Neuroligin-1 and SynCAM Adhe-
sion proteins like NL1 and SynCAM link the pre- and postsynaptic side to one another,
providing both structural stability and bidirectional signaling. This project focusses on
the role of NL1 and SynCAM in synaptic development. Both proteins play critical roles
in neuronal target recognition, as well as synapse formation, stabilization, and maturation
during development. These roles will be discussed in detail in the Theory Section. This
section will focus on the structure of NL1 and SynCAM, as well as their role in other
aspects of synaptic function separate from development. It will also briefly describe the
structure and function of neuroligin’s presynaptic binding partner, the neurexins.
Neuroligins were identified based on their role as postsynaptic cell-adhesion molecules that
are located at excitatory synapses. They bind to the neurexins to form heterodimers at
the synaptic cleft. Neuroligins are not capable of homomeric interactions. There are five
human genes that code for the neuroligins (NL1-5); each individual neuroligin has a specific
neurexin binding partner. NL1 is one of three neuroligins that binds to beta-neurexins.
The neuroligin family members show significant sequence homology, but differ more in the
intracellular than extracellular domains. This suggests that the extracellular domain is
responsible for linking the pre- and postsynaptic sides in a conserved manner, while the
intracellular domain is involved in the transport of specific neuroligins to the appropriate
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synapses and also in the recruitment of different postsynaptic components to different types
of synapses [29]. The structure of NL1 is shown below in Figure 3.
Intracellularly, postsynaptic NL1 links to scaffolding proteins like PSD-95, and is found
clustered with NMDAR subunits. NL1 are only present at glutamatergic excitatory synapses
and are not found at inhibitory connections like GABAergic synapses [50]. Extracellu-
larly, neuroligins contain a cholinesterase-like domain, the region of the protein where the
molecule binds to presynaptic neurexins. Unlike a typical cholinesterase-domain (found
in proteins like Acetylcholinesterase), this region on neuroligins does not have enzymatic
activity, but is able to mediate the binding of the two adhesion molecules similar to en-
zyme/substrate interactions [29].
The neurexins themselves are encoded by three genes. These undergo splice variation
to produce the two distinct categories of neurexins that are found, the alpha- and beta-
neurexins. The two splice variants have what is called an LNS domain, which binds to
the cholinesterase- domain of the neuroligins to cause the cell adhesion. While the alpha-
neurexin has six LNS domains, the beta-neurexin has only one. In addition, the neurexins
contain PDZ binding domains that can potentially recruit presynpatic constituents to the
synapse [29].
Functionally, the interaction of NL1 with beta-neurexin recruits the appropriate pre- and
postsynaptic molecules (i.e. postsynaptic receptors and presynaptic NT vesicles) to the
synapse, and then uses scaffolding molecules to oppose these proteins to one another at
the synaptic terminal. All neuroligin members bind to the scaffolding protein PSD-95,
which then assembles protein complexes that include both the NMDARs (directly) and
AMPARs (indirectly through a second scaffolding protein, Stargazin). The binding of the
two proteins may also recruit other regulatory molecules, like kinases, to the synapse, which
can then alter synaptic function as needed [29].
SynCAMs, also called IGSF4, are another family of cell adhesion molecules that are studied
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in this project. These molecules are part of the immunoglobin superfamily, a large group of
cell adhesion molecules. Immunohistochemical studies in drosophila and rats have shown
that this is a cell adhesion molecule that forms homomeric interactions. The possibility of
heteromeric interactions by SynCAM have not been ruled out, but potential heteromeric
binding partners have not yet been identified. The structure of SynCAM is shown in
Figure 3. The molecule has three ”Ig domains” that bind to other cell adhesion molecules.
The intracellular portion of SynCAM contains a PDZ domain that can then bind to other
scaffolding and signaling molecules that also contain the domain [55].
SynCAM is not only involved in synapse development and function, but also acts as a
tumor suppressor for lung cancer, as an adhesion molecule for sperm cell precursors, and
as a cell adhesion molecule for mast cells. Because it was discovered by different researchers
independently, the protein has been given three different names in the literature: TSLC1,
SgIGSF, and SynCAM [55].
Including its role in synaptic development, which will be discussed in the Theory Section,
SynCAM has functions in modulating synaptic transmission. Transfection of SynCAM into
hippocampal neurons increases the frequency of spontaneous miniature excitatory postsy-
naptic potentials, a measure of the frequency of synaptic activity. This increased synaptic
activity can be due to either an increase in the number of synapses (a developmental pro-
cess), or an increase in the frequency of NT release from existing synapses (a modulation
process). Immunocytochemical studies measuring the number of synapses, combined with
electrophysiological studies measuring synaptic release, show that SynCAM is actually
involved in both processes [55].
2.1.2.2 Scaffolding Proteins: PSD-95 and Stargazin As previously mentioned,
the scaffolding proteins create complex molecular networks that cluster proteins at appro-
priate areas in the synaptic terminal. Scaffolding proteins are not studied in this project;
however, understanding their role is important in identifying mechanisms of synaptic plas-
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Figure 3: A simplified schematic showing the molecular structure of the two postsynap-
tic cell adhesion molecules studied in this project: NL1 and SynCAM. The extracellular
portion of the protein is shown to the left of the arrow, and the intracellular domain is
shown to the right. Both molecules have a transmembrane domain and a PDZ domain.
SynCAM has three extracellular IG domains that bind to presynaptic SynCAM, while NL
has a cholinesterase-like domain that binds to presynaptic neurexins. SynCAM also has
an additional intracellular protein binding domain.
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ticity as well as changes in glutamate receptor function. This section will provide a brief
overview of two scaffolding proteins often associated with the function of the glutamate
receptors, PSD-95 and Stargazin. Since this project also uses a simplified model to avoid
potential compensatory mechanisms inherent in biological systems, this section will also
cover a few knockout experiments of PSD-95 in mice. The results of these experiments
are commonly used as an example of a compensatory mechanisms in neurobiology, since
the knockouts produce results that are conflict with in vitro studies and existing LTP
models.
The PSD-95 family of proteins is encoded by four genes. The protein contains three
different PDZ domains, as well as two other domains important in protein interactions, the
SH3 and GK domains. The PDZ domains can cluster together and create multimers that
can recruit NMDARs, AMPARs, and a variety of other proteins like potassium channels
and kinases, facilitating signal-coupling at the synapse. Glutamate receptor clustering
appears to be independent of PSD-95 since mutations to PSD-95 do not affect normal
clustering. However, the localization of receptor clusters to the synapse is disrupted by
PSD-95 mutations, since in neurons with these mutations many receptor clusters are found
extrasynaptically. The interaction by PSD-95 with NL1, which then interacts with beta-
neurexin, allows for presynaptic proteins to be located in register with the postsynaptic
density. Since the NL-beta-neurexin interaction is critical for neural targeting and synaptic
development, it is conceivable that PSD-95 plays a role during synaptogenesis as well
[25].
PSD-95 also links to Stargazins, which then bind to AMPARs. Since LTP is characterized
by increase in AMPAR currents, one model of LTP is that the calcium influx through
NMDARs at the synapse causes downstream signaling that allows for PSD-95 to recruit
Stargazins to the synapse, and the Stargazins bring with them AMPAR subunits like GluR1
[25].
While the structural role of PSD-95 and its interactions with other proteins is relatively well
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characterized, the functional role of this protein is not well understood. Experiments on
PSD-95 are often used as examples of how potential compensatory mechanisms can create
results seemingly in conflict with one another. PSD-95 knockout mice have impaired spatial
learning and defective LTD, but actually have enhanced LTP [34]. However, an analysis
of synaptic currents in in vitro cultures with PSD-95 knockout or overexpression suggest
that PSD-95 plays an active role in producing LTP via the recruitment of Stargazin, as
previously described. This conflict between the in vitro results and the phenotype of
PSD-95 knockouts needs to be reconciled, but it is likely that in the in vivo system,
another protein is substituting for the removed PSD-95 and producing an altered response
[25].
2.1.3 Overview of the Glutamate Receptors
As previously mentioned, most excitatory activity in the mammalian central nervous sys-
tem is mediated by the glutamate receptors. These receptors also are involved in the
strengthening or weakening of synapses through LTP and LTD. Glutamate receptors are
involved in pathophysiology, since excessive activation of these receptors during traumatic
brain injury or epileptic seizures can lead to neuronal death by a mechanism called exci-
totoxicity. Understanding the role of receptor expression and activity during development
and disease remains a critical research question [37].
There are two main classes of glutamate receptors- the ionotropic and the metabotropic
receptors. Ionotropic receptors, which includes the AMPARs and NMDARs, are a family of
ligand-gated ion channels encoded by 18 different genes [33]. The metabotropic receptors
are membrane bound receptors that interact with G-proteins to produce second messengers
that indirectly produce the postsynaptic response. Because of their mechanism of action,
ionotropic receptors mediate ”fast” excitatory transmission, while metabotropic receptors
result in slower, but more long-term responses due to the cascading effects of second mes-
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senger signaling systems [37]. The ionotropic receptors can be divided into three main
families on the basis of the specificity of specific agonists: the kainate receptors, AMPARs,
and NMDARs (a fourth family, the delta receptors, is sometimes included in the literature).
This project focuses on AMPARs and NMDARs.
Each receptor is composed of four subunits. The different types of subunits show tremen-
dous diversity- currently there are four known AMPAR subunits (GluR1, GluR2, GluR3,
and GluR4) and seven known NMDAR subunits (NR1, NR2A, NR2B, NR2C, NR2D,
NR3A, and NR3B). Each NR2 subunit has its own specific glutamate-binding site, and
each NR1 and NR3 subunit has a glycine binding-site. Modeling studies of glutamate re-
ceptors suggest that the mechanism by which they open involves the binding of agonist to
the subunit, creating a torque on the protein that leads to channel opening [33].
The receptor subunits typically have a large, N-terminus extracellular domain, three hy-
drophobic transmembrane domains, and an intracellular C-terminus. There is another
hydrophobic, region does not make a complete pass through the membrane, but makes a
turn within the membrane (called a re-entrant membrane loop) and forms the P, or Pore,
domain. The P domain from the four subunits surrounds the water-filled pore that allows
ions to pass through the membrane.The presence of this re-entrant loop provides a struc-
tural distinction between the glutamate receptors and other receptors found at excitatory
synapses, such as the GABA and acetylcholine receptors [11].
Structural schematics for both the NMDAR and AMPAR are shown in Figure 4.
2.1.3.1 Postsynaptic Receptors: AMPA Receptor Among the three families of
glutamate receptors, AMPARs are the most critical in mediating the fast responses at
excitatory synapses in the mammalian CNS. This project studies one class of AMPARs,
the homomeric GluR1 AMPAR. This section will cover the molecular structure, biophysical
properties, pharmacology, and physiology of these receptors.
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Figure 4: A simplified schematic showing the molecular structure of the two glutamate
receptors studied in this project, the AMPAR and NMDAR. These receptors bind to the
neurotransmitter glutamate and then open to allow the flow of specific cations through the
channel. The separate subunits, as well as the neurotransmitter binding sites and ion per-
meabilities, are labeled. Also shown is the magnesium block, which prevents the NMDAR
from being activated unless both neurotransmitter and a postsynaptic depolarization are
detected.
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As previously mentioned, the AMPARs is composed of four separate subunits, which are all
approximately 900 amino acids in size and have about 70 % sequence homology between
them [37]. AMPARs can be either homomeric (composed of identical subunits) or het-
eromeric (composed of different subunits). Immunoprecipitaiton studies have found that
AMPARs are typically GluR2/GluR1 or GluR2/GluR3 heteromers, but there are GluR1
homomers present in various different brain regions. The distribution of different types of
AMPARs vary not only between different brain regions, but also within individual neurons
themselves; studies combining immunohistochemical staining for specific AMPAR subunits
and electrophysiological measurements of currents have shown AMPAR with different sub-
units combinations within the same neuron [11].
The subunit compositions of a specific receptor results in profound changes in the biophysi-
cal properties and physiological function of the receptor. AMPARs are distributed broadly
through the CNS, although there are often differences in the amounts in different brain re-
gions. High levels of AMPARs are found in the hippocampus, cerebral cortex, deep cortex,
brainstem, and basal ganglia. Lower levels were found in other regions like the cerebellum.
In situ hybridization to determine the subunit composition of AMPARs at different brain
regions show that in the hippocampus the receptors are composed of GluR1, GluR2, and
GluR3 (including GluR1 homomers, used in these experiments), while in cerebral cortex
all four subunits are present, with GluR2 found in all cortical layers and GluR1, GluR3,
and GluR4 expression differing between layers [37].
AMPARs are permeable to sodium and potassium ions. Studies expressing combinations
of receptor subunits in HEK293 cells and measuring ionic currents show that homomeric
GluR2 receptors have almost no calcium ion permeability, while homomeric GluR1, GluR3,
or GluR4 channels are highly permeable to calcium ions and allow a substantial inward flux
of the ion. For example, the ratio of permeability to calcium compared to permeability to
sodium and potassium in homomeric GluR1 is 2.34 [11]. Heteromeric channels with GluR2
combined with either GluR1, GluR3, or GluR4 results in channels with little calcium
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permeability [23]. These experiments suggest that it is the GluR2 subunit that prevents
calcium flow through this channel. The amino acid within the P loop of AMPARs that
determines calcium permeability is a charged arginine in GluR2 subunits but a noncharged
glutamine in the other subunits. Interestingly, this arginine is NOT encoded in the GluR2
DNA, but introduced into the protein by RNA editing. In mature adult brains, all GluR2
is expressed in this edited form but in embryonic brains, a percentage of GluR2 subunits
do not undergo RNA editing and therefore form AMPAR that has calcium permeability
[37].
AMPARs have short time constants for both opening and closing, reflecting its role in
mediating fast synaptic transmission. The receptor closes more rapidly than the time it
takes glutamate to diffuse out of the synapse, and so the mechanism of closing is likely
due to desensitization (closing of the receptor even in the presence of agonist) rather than
deactivation (removal of the agonist) [11].
Pharmacologically, there are several molecules that act as antagonists to the AMPAR;
these include CNQX, DNQX and YM90K. These molecules are often used by researchers
to block AMPAR currents [37].
Two final points to note about the AMPAR involve the functional significance of calcium
permeability through some of these receptors, as well as the pathophysiology of AMPAR.
Some cells in the CNS, particularly hippocampal interneurons and neocortical interneu-
rons, have AMPAR with high calcium permeability. Experimental analysis of the receptor
types in these cells using RT-PCR has shown that these cells contain a decreased amount of
the GluR2 subunit relative to the other AMPAR subunits. This is expected since GluR2
confers calcium impermeability. Researchers hypothesize that, in addition to the NM-
DARs, these calcium- permeable AMPARs (i.e. homomeric GluR1 receptors) play a role
in providing calcium influx triggered by synaptic activity; calcium can then function as
a signaling molecule and play a role in modulating synaptic function. In line with this
hypothesis, hippocampal neurons containing calcium-permeable AMPARs had markedly
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enhanced LTP, a process believed to involve calcium influx into the cell. Furthermore,
this LTP could be induced in the presence of blockers for NMDARs, which is the recep-
tor typically thought to be involved in synaptic plasticity. These results suggest that the
calcium influx through AMPARs play a critical physiological role, particularly in learning
and memory. There is also overwhelming evidence that excessive calcium influx can occur
through calcium-permeable AMPARs during brain injury, and AMPAR antagonists, like
CNQX and DNQX can prevent neuronal death caused by ischemia in the hippocampus
[37].
2.1.3.2 Postsynaptic Receptors: NMDA Receptor The NMDAR produces post-
synaptic responses that are slower and more prolonged than the AMPAR, and because
of their molecular and biophysical characteristics are often thought to be implicated in
processes like learning and memory. This project uses the NR1/NR2A type of NMDAR.
This section will provide a brief overview of the molecular structure, biophysical properties,
pharmacology, and physiology of these receptors.
The fundamental differences between the AMPAR and NMDAR that result in their dif-
ferent physiological roles include the NMDARs increased permeability to calcium ions,
slow kinetics, and voltage-dependent magnesium block. As previously mentioned, there
are seven genes for NMDAR subunits (NR1, NR2A, NR2B, NR2C, NR2D, NR3A, and
NR3B). Initial experiments on Xenopus oocytes found that transfection of just the NR1
subunit was sufficient to produce functional receptors. However, this same experiment in
mammalian cells found that NR1 homomers only produce a small postsynaptic response,
and NR2 homomers do not form functional channels. Eventually, it was found that an
endogenous Xenopus protein associated with NR1 to form functional channels, and it is
now accepted that in mammalian cells, NMDARs cannot form homomeric channels. It is
hypothesized that two NR1 subunits must be coupled with two NR2 subunits (though it
is not necessary to have the same two NR2 subunits in a given channel) [14]. Because
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all NMDARs express the NR1 subunit but differ in their NR2 composition, the NR1 can
be thought of as a ”fundamental” subunit while the NR2 serves a more modulatory role.
From a genetics perspective, the sequence homology between the NR1 and NR2 subunits
are quite low compared to the homology between different NR2 subunits (18 % compared
to 50 %) [11, 37].
Immunohistochemical stainings for the NMDARs have shown that these receptors are
distributed throughout the mammalian central nervous system, with a particularly large
amount found in the forebrain and hippocampus. In situ hybridization shows that NR1
mRNA is found throughout the central nervous system, while the four NR2 subunits have
much more specific distributions. The NR2A is found throughout the brain, with a par-
ticular emphasis on the cerebral cortex, hippocampus, and cerebellum. The other three
subunits are found in the forebrain, cortex, hippocampus, basal ganglia, thalamus, brain
stem, and cerebellum. The expression of NMDAR subunits changes during the course of
development; in situ hybridization studies have shown that the NR2B and NR2D receptors
are primarily expressed before birth, while the NR2A and NR2C show increased expression
after birth. This shift is most substantial in the cerebellum, and is dependent on activity.
In neurons that are cultured in vitro, the switch from NR2B to NR2A is normally seen,
but NR2B expression remains high if the culture is chronically exposed to TTX, a sodium
channel blocker that prevents action potential generation. It has been hypothesized that
this shift helps tailor the receptor that is expressed in different brain regions to that region’s
neurological task. [37].
Like the AMPAR, the NMDAR is permeable to monovalent cations like sodium and potas-
sium. However, the NMDAR differs from the AMPAR in its permeability to divalent
cations. The receptor shows substantial permeable to calcium, and is even more perme-
able than homomeric GluR1 AMPARs. While the ratio of permeability of calcium to
sodium and potassium in the GluR1 R is 2.34, in the NMDAR it ranges from 3.10-11 [11].
Experiments expressing NMDARs in HEK cells, bathing the cells in media containing
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physiological amounts of cations, and measuring the percentage of ionic currents through
the channel show that about 10 % of the total NMDAR current is carried by calcium.
This relatively large calcium influx through the channel functions as a second messenger
molecule at postsynapses, altering synaptic structure and protein function in a long-lasting
way [37, 14].
NMDARs also show a voltage-dependent magnesium block- unless the membrane potential
is slightly depolarized, the receptor pore is blocked by magnesium ions.The mechanism of
this blockage can be explained by understanding the structure of the receptor. At the
resting voltage the magnesium ion in essence gets ”stuck” inside the channel, blocking
current flow through the receptor. Because magnesium is a positive ion, a hyperpolarized
membrane would attract the ion, and so it would be more likely to move towards the inside
of the channel; depolarizing the membrane, which would make the inside more positive,
would result in less of an attractive force of the magnesium ion to the inside of the cell, and
this would result in the movement of the ion out of the pore. The voltage block is much
stronger for NR1/NR2A and NR1/NR2B channel than the NR1/NR2C and NR1/NR2D
channels; in NR1/NR2A or NR1/NR2B channels, the block is removed only at -25 mV,
compared to -45mV for the other two types of channels [37].
In order for the NMDAR to be activated, the receptor needs to bind to both glutamate
and glycine. In physiological systems, it appears that glutamate is the neurotransmitter
released by the presynapse, while sufficient glycine is present in the extracellular solution
for partial occupation of the glycine-binding site. Research has shown that mutations
on the NR1 subunit reduced the receptor’s affinity for glycine, while mutations on the
NR2 subunit reduced the affinity affinity for glutamate. Thus, the NR1 binding site is for
glycine, while the NR2 is for glutamate [11, 37].
In experiments, pharmacological agents used to block NMDAR include MK-801, AP5,
CNQX, nitric oxide, and D-APV [37].
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The kinetics of the NMDAR are characterized by both slower opening and closing times
than the AMPAR. However, glutamate binds to the NMDAR with much greater affinity
than it binds to the AMPAR [11].
Three critical characteristics are crucial for the role of the NMDAR in synaptic plasticity:
the Mg block at resting potentials, the significant permeability to calcium, and its slow
receptor kinetics. This allows the receptor to function as a molecular ”coincidence detector”
that only opens in response to glutamate application following an initial depolarization,
and produces calcium ion influx ; calcium then acts as a second messenger molecule in
various biological pathways. AMPARs and NMDARs have been found to be colocalized
and are often simultaneously activated by glutamate released by the presynapse. One model
of synaptic plasticity then involves the AMPAR, with its lower affinity to glutamate but
faster kinetics, producing a ”quick” response to presynaptic activity, while the NMDAR,
with its stronger affinity for the neurotransmitter but slower kinetics, producing a more
prolonged responses that can ultimately alter synaptic strength [37]. The calcium influx
could play a role in these changes at the synapse, since both the NMDAR and AMPAR are
phosphorylated by CAMKII, a kinase that is activated by calcium. This phosphorylation
results in increased current through the AMPAR, which may account for the increased
current flow at the postsynapse following LTP [11].
Finally, NMDARs are critical in both development (discussed in the Theory Section) and
injury. Traumatic brain injuries, strokes, and seizures often result in the overactivation
of the NMDAR, which causes excessive calcium influx that ultimately leads to neuronal
death. There is also some evidence to suggest that NMDAR activity is involved in neu-
rodegenerative disorders [11].
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2.1.4 Structure and Function of the Presynapse
This section will provide a brief overview of the structure and function of the presynapse
as it relates to synaptic transmission. For the purposes of this project, the key presy-
naptic proteins that are immunolabeled are the priming protein synaptobrevin/VAMP,
the calcium detection protein synaptotagmin, and the synapsins, which are involved in
maintaining a reserve pool of NT vesicles.
The region on the presynapse that is analogous to the postsynaptic density is called the
presynaptic active zone. The active zone contains the voltage-gated calcium channels
that are opened by the incoming action potential, as well as the NT vesicles. These are
attached to specific proteins to form the SNARE apparatus, and fuse with with the plasma
membrane and release NT into the synaptic cleft by exocytosis following calcium influx.
In addition to the active zone, there is a region of the presynapse called the reserve pool,
where excess NT vesicles are stored and recruited to the active zone if repeated neuronal
activity depletes the NT vesicles there. The molecules that are involved in forming the
reserve pool are the synapsins. Experimental disruption of the synapsin genes have been
shown to reduce the number of NT vesicles in the reserve pool [20]. At the active zone, the
proteins that are involved in the docking and release of NT vesicles are collective called
the SNARE proteins, and include VAMP. An additional protein called synaptotagmin is
involved in detecting the increased intracellular calcium and initiating vesicle release.
Because the active zone is involved in vesicle exocytosis and re-uptake, an extensive cy-
toskeletal network is also present, with a variety of cytoskeletal-associated proteins present
at the presynapse. These proteins, which include Munc, Rim, Piccolo, and Bassoon, are
involved in a variety of functions, including vesicle docking, vesicle fusion, NT reuptake,
and the modulation of the reserve pool [20].
Just like the postsynapse, the presynapse is a dynamic structure. Specifically, changes in
NT release occur during LTP, and these are mediated by the synapsins. Synapsins bind to
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a variety of presynaptic proteins, and play a role in the phosphorylation dependent increase
in NT release following AP generation. Synapsins also play a role in maintaining, and often
increasing the size of, the ”reserve pool” of NT vesicles for use during frequent presynaptic
activity. Changes in the number of vesicles in the reserve pool correspond to changes in the
stability and the strength of the synapse, and so labeling synapsin at synaptic terminals
can provide insight into changes in presynaptic morphology and function.
A schematic diagram of the presynapse can be seen in Figure 5.
2.2 MOLECULAR BIOLOGY
This project utilizes transient transfection to introduce neuronal genes encoded on plasmids
into non-neuronal cells. The non-neuronal cells then express the proteins coded for by
the DNA sequence. Protein expression can then be confirmed using Western Blots and
Immunocytochemistry.
This section will review the basic molecular biology used in the experimental methods of
this project, including plasmid identification, plasmid purification, mammalian cell trans-
fection, Western Blotting, and immunocytochemistry.
2.2.1 Plasmids and Transfection
Plasmids are circular strands of DNA typically found in bacteria (and also some yeast) that
are separate from the chromosomal DNA. Plasmid size can be as large as 1000 kilobase
pairs, and in nature they provide a mechanism for gene transfer within an existing bacterial
colony without the need for reproduction. In nature, plasmids either encode for genes that
provide resistance to antibiotics or other toxins or provide the means to fill an environmental
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Figure 5: A diagram of the presynaptic active zone. Synaptotagmins and VAMPs are
shown, while synapsins are not because they are not located in the active zone, but rather
regulate the reserve pool.
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niche (like the ability to fix elemental nitrogen). Molecular biology research often involves
introducing proteins of interest into cells that normally do not express these proteins,
or express them at low levels. This process involves incorporating genes of interest into
existing plasmid DNA, growing the plasmids in bacteria, harvesting the plasmids, and then
introducing them into the desired cells using techniques called transfection [28].
The structure of a typical research plasmid contains several specific sites within the DNA
sequence, including: an origin of replication, where bacteria could begin to replicate the
DNA; mammalian promoters, which allow the DNA sequence following the region to be
transcribed into RNA using the transfected cell’s DNA machinery; several restriction sites,
which are specific nucleotide sequences that are cut by restriction enzymes and can be
used for both gene insertion and plasmid identification; multiple cloning sites, which are
short regions containing several restriction sites that allow the desired DNA sequence to
be introduced into the plasmid; and a gene encoding for antibiotic resistance, which allows
for the identification of bacteria containing the plasmid, making purification easier [28]. A
structure of a typical plasmid is shown below in Figure 6
Plasmids for different genes can be prepared by digesting the multiple cloning sites with
appropriate restriction enzymes to create a gap in the plasmid, then inserting the gene of
interest into this cloning site using a ligase enzyme. Restriction enzymes recognize and cut
specific DNA sequences. For example, EcoR1 recognizes GAATTC and cuts between the G
and the A. This creates ”sticky ends,” where the nucleotide sequence has no complementary
base pair attached, and this can be used to insert a gene sequence that has matching ”sticky
ends.” As an example, digesting a plasmid with EcoR1 would expose a cloning site with G
and AATTC sticky ends; these can then be used to insert a gene with the sticky ends C and
TTAAG [28]. In this project, the plasmids were simply obtained from other laboratories
that designed them beforehand.
Once plasmids are either created or obtained, they can be introduced into bacteria (usually
E. Coli) so the cell machinery can duplicate the DNA, amplifying the number of copies of
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Figure 6: A diagram of the plasmid for NL1 that was used in this experiment. The
promotor, gene for antibiotic resistance, and gene coding for NL1 are shown.
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the plasmid. This process is called ”transformation,” and was done in this project using
the heat shock method. In this process, the plasmid and bacteria are incubated together at
a low temperature in an ice bath. Then, the mixture is placed in warm water, just above
physiological temperature (42C). This sudden increase in temperature causes pores in the
bacteria to suddenly increase in size, allowing the DNA to enter the bacteria [28].
The bacteria is then allowed to grow on medium supplemented with the antibiotic that the
plasmid encodes resistance for; only bacteria that have actually incorporated the plasmid
will be able to survive and create colonies. Individual colonies can then be selected and
cultured, and the DNA and protein within the cell can be obtained by alkaline lysis. This
is a process where a strong base (e.g. sodium hydroxide) breaks the cell wall. A detergent
(e.g. sodium dodecyl sulfate) then dissolves the plasma membrane. The DNA can then
be separated from bacterial proteins and chromosomal DNA using column purification,
which separates components based on charge and size. The DNA can then be further
purified using ethanol precipitation or phenol/chloroform extraction, which separates the
components based on solubility [28].
The identity of this amplified, purified plasmid can then be determined use restriction
digests and gel electrophoresis. This process involves using restriction enzymes to cut the
plasmid at specific sites, resulting in DNA fragments. The cut DNA can then be loaded into
an agarose gel. Agarose gels are composed of crosslinked polymers with small pores for the
DNA to pass through. When a voltage is then applied to the gel, negatively charged DNA
fragments will travel through the gel at different speeds, with the larger, more negative
fragments moving more slowly through the gel. The number and size of the fragments
can then be compared to what is expected in order to confirm the plasmid identity. Once
the plasmid identity is confirmed, plasmid purification can occur on a much larger scale to
obtain several hundred milligrams of DNA [28].
The obtained DNA can then be introduced to mammalian cells using a technique called
transfection. In this experiment, the mammalian cell used is the HEK293 cell, which will
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be discussed in more depth in the Theory Section. A variety of different techniques can be
used to introduce DNA into these cells, including using polycations, calcium phosphate,
liposome fusion, microinjection, electroporation, and protoplast fusion. However, all of
these techniques either are toxic to the cell, or have a poor efficiency. Because of these
issues, lipofectamine was used as a transfection agent. This is a cationic lipid that has been
shown to form lipid-DNA complexes that completely entrap the DNA and then fuse with
the cell membrane, producing transfections that are 100 times more efficient than other
techniques. There are problems with cell toxicity, but these can be avoided by removing
the lipofectamine agent from the media after the transfection is complete [15].
2.2.2 Western Blotting and Immunocytochemistry
Once HEK293 cells were transfected with the selected DNA, both the expression and the
appropriate localization of the protein had to be confirmed. The two methods that were
used to do this were Western Blotting and immunocytochemistry. This section will discuss
these two experimental methods.
2.2.2.1 Western Blotting Once the transfection has occurred, the cell population
can be collected using mechanical scraping, placed in a buffering solution, and then lysed
using detergent to break apart the cell membrane. The contents are then centrifuged to
separate the protein from the remaining cellular components. During the cell lysis stage,
protease inhibitor coctakils, which contain a variety of proteolysis inhibitors, are used to
prevent unwanted degradation of the protein sample [2].
The concentration of proteins within the sample can be determined using UV absorption.
Amino acids containing aromatic rings absorb UV light at 280 nm, and so the absorbance
at this wavelength can be used to calculate the protein concentration. Once this is done,
a standard amount of protein (typically 1-3 ug/uL, but ranging from 1-50 ug/ul) is loaded
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into a polyacrylamide gel, which is a gel composed of crosslinked polymers that are larger
than agarose, allowing proteins to pass through. These gels also contains a detergent (e.g.
SDS). The detergent is needed because, unlike DNA, proteins have irregular structures and
in order to separate them out strictly based on chain length, the polypeptide chain must
be denatured. Using SDS also normalizes the charge of the protein to its mass; since SDS
is negatively charged, and coats the protein, the charge of the SDS-protein complex is no
longer based on the protein’s amino acid sequence but instead proportional to the size of
the polypeptide [5].
Once the proteins are loaded into the gel, a voltage is applied across the gel and, based on
the same principles that agarose gels separate DNA, the protein moves through the poly-
acrylamide gel, separating based on size so that the smaller proteins move more quickly
through the gel while the larger ones move more slowly. Once the proteins have been
separated onto the gel, the proteins are transferred onto a PVDF membrane. This transfer
is done because the membrane is easier to handle than the gel. The transfer occurs by
sandwiching the membrane to the gel vertically and then running a current in the direc-
tion from the gel to the membrane. The current pulls the proteins from the gel into the
membrane, maintaining the organization that the proteins had on the actual gel [52].
Once the proteins are transferred to the membrane, a solution must be added to block
nonspecific binding sites. This is because the membrane readily binds proteins, and so
adding antibodies (which themselves are proteins) to probe for the polypeptide of interest
would ultimately lead to false positives on the membrane. Typically, a buffered solution
of either 5 % bovine serum albumen or 5 % powdered milk is used to coat the parts of
the membrane that do not contain sample protein. After this step, a buffered solution
containing antibodies against the protein of interest are added at a concentration of 0.5
to 5 ug/mL and the membrane is incubated for 1 to 3 hours. The primary antibody is
produced by a host animal (e.g. rabbit, goat, or chicken) and directed against a specific
part of the protein of interest, called an epitope. The epitope can either be an inherent
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part of the protein of interest, or can be a small peptide fragment (called a ”tag”) that is
artificially added to the gene before incorporating the gene into the plasmid. This allows
for the probing of transfected protein separate from endogenous expression [5].
A secondary antibody is then added. This antibody is directed against epitopes specific
to the primary antibody’s host animal, and also contains an enzyme like horseradish per-
oxidase, which produces light when a chemiluminescent substrate is added. After another
incubation, the light produced by the interaction of the chemiluminescent substrate and the
horseradish peroxidase can be recorded onto film paper in order to determine the potential
presence of the protein of interest [5].
2.2.2.2 Immunocytochemistry Another method to determine the expression of a
protein in a cell is immunocytochemistry. The added benefit of using this technique is that
the actual localization of the protein within the cell can be determined. For this project,
this technique can be used to not only confirm that membrane proteins are being expressed,
but also that they are being targeted to the plasma membrane. This is essential since the
heterologous synapses are formed on the membrane of the non-neuronal cell, and so the
proteins of interest need to be targeted to the cell surface.
Immunocytochemistry is similar to standard immunohistochemistry protocols except the
staining is done on dissociated cells rather than sliced tissue. Typically, the cells are
seeded onto a coverslip either before or after transfection so that the slip can be placed on
a microscope slide after staining for easy viewing.
For this procedure, the proteins are first fixed, which allows the cells to be as close to the
biological structure as possible by preventing enzymatic destruction, contamination, and
structural degradation of the sample. Fixation is achieved either with ice-cold methanol
or 4 % paraformaldehyde. In this project, paraformaldahyde is used as the fixative; this
requires the sample to be permeabilized as well, so that the cells in the sample have
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holes within the plasma membrane for antibodies to reach intracellular proteins. This
is achieved using a gentle detergent like Triton-X100. After permeabilization, the cell
sample undergoes a process similar to Western Blotting. The sample is exposed to 5 %
bovine serum albumin to block non-specific binding sites, then exposed to primary and
secondary antibodies for the protein of interest. Just like in Western Blots, the primary
antibodies are produced by a host animal and directed against an epitope of the protein of
interest (again, either a peptide segment intrinsic to the protein, or a tag that is artificially
inserted). The secondary antibody is directed against specific epitopes for the host animal
of the primary antibody. In the case of immunocytochemistry, the secondary antibodies
do not contain horseradish peroxidase, but fluorescent tags instead. These tags are small
polypeptide sequences that absorb light at a specific wavelength, and emit light at another.
For example, some antibodies emit green light at about 488 nm, while others emit red
light at about 555nm. In this way, immunocytochemistry can stain and differentiate two
proteins of interest simultaneously. The samples can then be viewed under a microscope
to determine protein expression and localization [42].
2.3 MICROSCOPY
Once cells are stained by immunocytochemistry, microscopy is used to examine the samples
for fluorescence. In this project, two forms of microscopy were used- standard bright
field microscopy and confocal laser scanning microscopy. This section will provide a brief
overview of these two techniques.
In bright field microscopy, the sample is illuminated using a light from below the slide
and observed through an objective above the slide. Fluorescent probes can be detected by
shining the excitation light from below the sample using a filter that absorbs all wavelengths
except the wavelength of excitation, and observing the emitted light from above. This
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setup can reach magnifications of up to 1000x, but in standard laboratory settings typical
magnifications are in the 40-63X range, and are used as an initial observation because of its
simplicity. It has low contrast and resolution, and so it cannot be used for more advanced
fluorescent analysis [38].
Confocal laser scanning microscopy is a more advanced viewing system that allows for
increased resolution and contrast. In this technique, the light source is a laser, and a
pinhole eliminates light that is out-of-focus from the plane that is being viewed. By taking
images of several planes through the sample, a 3-dimensional image can be reconstructed
by superimposing the slices on top of one another, pixel-by-pixel, using a computer. By
adjusting the frequency of light emitted by the laser, the microscope can produce light
with the wavelength of excitation for fluorescent proteins [38].
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3.0 THEORY
3.1 EARLY DEVELOPMENTAL NEUROBIOLOGY- SYNAPTOGENESIS
The structure of the pre- and postsynapse were discussed in previous sections. This project
centers on synaptogenesis, which is the formation of synapses. Each neuron has anywhere
from one to several hundred thousand connections. How a neuron forms and maintains
these synapses is one main focus of neurobiological research. The formation of synapses
typically involves two general phases: the structural binding of the two neurons and the
recruitment of necessary synaptic components (a process termed synapse formation or initi-
ation); and an activity-dependent stabilization or elimination (termed synapse validation).
Synapse validation not only eliminates unneeded synapses, but also creates appropriate cir-
cuits and topographic maps. Both of these phases require proper communication between
the axon and dendrite [?]. This section will provide a detailed overview of the process of
synaptogenesis, with separate subsections for synaptic initiation and synaptic validation.
The specific roles of NL1 and SynCAM, as well as NMDAR and AMPAR, will also be
discussed in subsequent sections.
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3.1.1 Synaptic Initiation
This section will provide an overview of the process of synaptic initiation, from the contact
of axons and dendrites through the recruitment of pre- and postsynaptic proteins.
Synaptogenesis in the CNS begins when the axon of one neuron elongates outward and
initiates contact with a potential target. Real-time imaging studies have shown that this
elongation is an extremely dynamic process, with both the axon and dendrite display-
ing substantial motility, migrating outward and then retracting [9]. In order to create
a synapse, the two cells must create an initial contact that has stable sites of adhesion.
This stable structure then allows for the beginning of synapse formation and the develop-
ment of pre- and postsynaptic specialization. While other simpler synaptic structures like
the neuromuscular junction have clearly separate processes for target identification and
synapse induction, with specific molecules that have unique roles during each phase, the
demarcation between the identification of potential synaptic targets and the induction of
synapse formation is often unclear at CNS synapses. For this reason, it is often believed
that these processes are complementary, and that both are mediated by a variety of cell
adhesion molecules. Among these are the cadherins and the neuroligins [19].
The cadherins are cell adhesion molecules that are found throughout the body; the specific
variant of cadherins found at synapses are termed N-Cadherins. These proteins are lo-
cated at sites of both spontaneous and activity-dependent synaptogenesis. However, these
proteins do not appear to be required for synapse formation, since the elimination of N-
cadherins using siRNA does not alter either excitatory or inhibitory synaptogenesis. The
interesting result from studying N-cadherin knockouts is that the presynaptic binding part-
ner for these proteins, the beta-catenins, are not lost at synapses, suggesting that there are
other cell adhesion molecules that are filling in as a compensatory mechanism in knockout
mice [19].
The neuroligins also play a critical role in this developmental process. The fact that neuroli-
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gin expressed in non-neuronal cells has been shown to initiate the formation of presynapses
on contacting axons, and the discovery that this synapse formation is eliminated by the ad-
dition of soluble beta-neurexin, supports the belief that the neuroligin-neurexin interaction
is critical for the initial formation of synaptic connections. However, there is a definite lack
of clarity regarding the postsynaptic molecular mechanisms involved in this process. For
example, the scaffolding protein that binds to neuroligin, PSD-95, is still targeted (along
with glutamate receptors) to the synapse during the initiation phase even if the domain on
PSD-95 that binds to neuroligin is mutated [19]. Furthermore, the mechanism of neuroligin
targeting to the synapse is not well understood; the initial hypothesis that PSD-95 brings
these proteins to the synapse has been disproved by research that reveals that neuroligin
targeting does require the extracellular domain of the protein but does not require the
domain that binds to PSD-95 [13].
In a previous section, the variety of genes encoding for neuroligins and their binding partner,
the neurexins, was mentioned. The importance of several different types of cell adhesion
molecules is believed to be critical during synapse initiation, because the complementary
expression of cell adhesion molecules by two neurons can allow for the formation of very
specific contact. Since the mechanism behind how specific sets of synapses form is not
known, a ”lock-and-key” hypothesis is an attractive model to explain the variety of different
synapses that are formed in the CNS [19].
Once the contact between the two neurons has formed, both cells recruit the appropriate
molecular constituents to the synaptic junction. The recruitment of postsynaptic gluta-
mate receptors is mediated by three different proteins: NARP, the EphB receptors, and
Syndecan. NARP has been shown to promote AMPAR clustering after it is released from
the postsynapse into the extracellular space. It is hypothesized that this protein binds
to the AMPAR on the extracellular domain and forms multimers that cause the receptor
clustering. It is not known what the mechanism of this clustering is, or what effect this
clustering has on the developmental process. The EphB receptors bind to the presynaptic
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adhesion molecule called the ephrins, and induce the clustering of the NMDAR that is
initiated by the binding between the extracellular domain of the NR1 subunit and the ex-
tracellular domain of the EphB receptor. While the Ephrin B proteins are not implicated in
synapse formation, they are aggregated shortly before the clustering of the NMDAR. This
suggests that they play a role in ”coupling” the clustering of pre- and postsynaptic proteins
so that they occur in sync during synaptogensis. Finally, syndecans are proteoglycans that
are shown to enhance the maturation of the postsynapse [19].
Following the induction of synapse formation, the presynaptic release machinery is rapidly
assembled, and within two hours of contact, presynaptic proteins like VAMP, synaptotag-
min, and synapsin are located at the synaptic terminal [9]. Experiments have shown that
the ability to release neurotransmitter is preceded by the recruitment of these proteins to
the presynaptic active zone, and detailed studies suggest that all of the neurotransmitter
vesicles, as well as the necessary proteins for exocytosis, are transported on two precursor
vesicles to the nerve terminal. These vesicles also contain the scaffolding proteins that link
the presynaptic active zone proteins together [19].
Unlike the presynapse, the postsynaptic receptor complexes are synthesized de novo, with
each protein in the complex recruited to the synapse independent of one another. This can
occur either simultaneously with presynaptic differentiation (e.g. in some areas of cortex)
or following presynaptic differentiation (e.g. in some areas of the hippocampus). Imaging
studies have shown that the scaffolding proteins like PSD-95 are actually recruited in a
gradual manner before the glutamate receptors. The exact role of individual scaffolding
molecules is unclear, and is complicated by the inherent complexity of the neurobiological
system. For example, PSD-95 knockouts do not have any alterations in postsynaptic assem-
bly during synaptogenesis, likely because other molecules in the postsynaptic density are
filling compensatory roles [?]. However, these neurons do have altered functional synapses
(as previously discussed) so the various scaffolding proteins are not playing redundant
roles.
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One final point to note about synaptic initiation is that imaging and electrophysiological
experiments have also shown that the AMPAR and NMDAR can be recruited independent
of one another, and that the receptor recruitment does not require activity [19]. Imaging
studies that examine changes in axon and dendritic morphology as PSD-95 is recruited
to the synapse reveals that the changes in protein composition parallel changes in the
morphology of neural outgrowth; postsynaptic filopodia change to more elaborate spines,
and 80 % of all axon branches occur at sites of stable synapses [9].
A schematic of the process of synaptic induction including both neuroligins and SynCAMs
is shown in Figure 7.
3.1.2 Synaptic Validation
This project looks specifically at the effect of glutamate receptor expression on synaptic
validation. This section will provide an overview of the general process; subsequent sections
will describe both changes in receptor expression that occurs during development and the
specific research examining the role of glutamate receptors in synaptic development.
Synapses are actively remodeled following the initial formation of the contact, and many are
either stabilized or eliminated in an activity-dependent manner. A schematic diagraming
this process is shown in Figure 8.
Several experiments have shown that the elimination of synapses is preceded by a decrease
in presynaptic activity, but it is not clear whether this is the only cause of synaptic elimi-
nation, or whether activity through different sets of receptors can drive elimination as well.
It is also unclear whether specific contacts are formed with the predisposition of being
eliminated. Some research has found that a few newly formed synapses do not recruit
presynaptic proteins, and these are quickly eliminated. Oftentimes, synapse elimination
involves the comparison of activity between different inputs; the postsynaptic neuron stabi-
lizes inputs that have synchronous activity and eliminates synapses that have asynchronous
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Figure 7: Diagram of synaptic initiation, showing the binding of both SynCAM and NL1
to presynaptic partners, resulting in the recruitment of synaptic vesicles to the presynaptic
active zone.
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Figure 8: This schematic depicts two types of synaptic dependent validation: synaptic
strengthening and synapse elimination. In both cases, presynaptic neurotransmitter is
released onto the postsynaptic neuron. Depending on the response by the postsynaptic
neuron, there is bidirectional signaling that either strengthens the initial contact (increasing
its size and amount of neurotransmitter) or eliminates the contact altogether.
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activity. This is summarized by the phrase coined by Hebb, ”Neurons that fire together,
wire together.” Synapse elimination is a rapid process, often occurring within two hours
of the initial formation of the contact. Importantly, synapse elimination is a local process
that occurs via signaling at the synaptic cleft; the elimination of the contact occurs before
the retraction of the axon [9].
It appears possible to have normal synapse initiation in the absence of neurotransmit-
ter release. For example, mice with mutations to proteins required for neurotransmitter
release (the SNARE proteins VAMP, syntaxin, or SNAP-25) form synapses that appear
structurally normal, and create proper circuitry in various brain regions. In vitro cultures
that are chronically exposed to neurotransmitter receptor blockers (CNQX or APV) also
form contacts that have appropriate clustering of synaptic proteins. These results suggest
that the initial stages of synaptogenesis do not require activity. However, activity plays
a critical role in the validation and stabilization of newly formed synapses. For example,
blocking either NMDAR or AMPAR decreased the size of synapses, suggesting a stabi-
lizing role for glutamate receptor activity. Either NMDAR or AMPAR blockade during
development also prevented cytoskeletal remodeling, which prevents the formation of new
synaptic sites. These results contrast with other experiments that suggest receptor activa-
tion plays a role in synapse elimination by noting that chronic (14 day) NMDAR blockade
increased synapse number. This conflict may be due in part to the fact that the receptors
are not acting alone, but in concert with other molecules like neuroligins, PSD-95, and
ephrins. These proteins may produce different effects on synaptic validation in response to
glutamate receptor activation [9].
One practical example of the importance of synaptic validation is the establishment of neu-
ral maps, like the topographic visual map in the thalamus and visual cortex that separates
inputs from each into eye-specific columns. This map, called Ocular Dominance Columns,
forms in an activity- dependent process that involves competitive neural activity. Initially,
the entire visual cortex is innervated by inputs from both eyes, but due to an activity-
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dependent process synapses are eliminated to form columns that receive inputs from one
eye or the other. Blockade of neural activity from one eye using the sodium channel blocker
TTX, or alteration of neural inputs by changing the frequency of the retinal waves from an
individual eye, causes an imbalance and prevents the formation of even columns. Therefore,
in this process it is not simply the presence of activity, or the total activity, but patterned
activation of specific receptors that drives synaptic elimination [9].
3.2 ROLE OF THE NEUROLIGINS IN SYNAPTOGENESIS
As previously mentioned, the interaction between neuroligins and presynaptic neurexins
functions to initiate synapse formation. Neuroligins are also involved in synapse validation,
and this section will cover recent research on the specific role of the neuroligins on the
entire process of synaptogenesis, focusing on NL1, the neuroligin variant studied in this
project.
One piece of data that suggests neuroligins play a role in initiating synapse formation is the
fact that both NL1 and NL2, when expressed in non-neuronal cells that are subsequently
cultured with neurons, triggers synaptic formation in contacting axons. This setup, where
neuronal proteins are expressed in non-neuronal cells and then cocultured with neurons to
see what effect their expression has on synaptogenesis, is called the heterologous synapse
system and is used as the experimental technique in this project. The details behind the
assay will be discussed more thoroughly in a subsequent section. Briefly, the experimenters
expressed NL1 and NL2 in HEK cells, cultured the cells with neurons, and observed synap-
tic vesicle clustering at the site of contact between the axon and the HEK cell. This vesicle
clustering was abolished either by mutation of the cholinesterase-like domain of NL or by
the addition of soluble beta-neurexin. This supports an active role of neuroligin-neurexin
binding in initiating synapse formation [46].
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Other experiments have supported the idea that neuroligin functions in initiating synaptic
formation, and also showed these synapses are subsequently modulated by the presence of
other postsynaptic proteins. Prange et al. showed that overexpression of PSD-95 results
in an increase in synapse size and frequency of neurotransmitter release only at excitatory
synapses, and also causes a reduced number of inhibitory synapses. Similarly, knockouts
of PSD-95 increased inhibitory and decreased inhibitory synapses. In both cases, the
total number of synapses remained constant. Using immunocytochemical analysis and
staining synapses for glutamate or GABA, researchers showed that overexpression of all
neuroligin genes results in an increase in both excitatory and inhibitory synapse number;
however, simultaneous overexpression of PSD-95 and NL abolishes the increased number
of inhibitory contacts. Taken together, these results suggest that the neuroligins establish
synapses regardless of type, and that the eventual identity of these synapses (excitatory
or inhibitory) and their subsequent maturation depends on the presence of specific post-
synaptic proteins like PSD-95 [39]. This result has been seen in a variety of different brain
regions, including cortex and hippocampus [6]
The different neuroligin genes appear to play different roles at excitatory and inhibitory
synapses, since NL1 is found at glutamatergic synapses but NL2 is found at GABAergic
synapses. Immunocytochemical and electrophysiological analysis shows that the addition of
soluble beta- neurexin results in a decrease in both frequency and amplitude of postsynaptic
responses at both excitatory and inhibitory synapses. This suggests that the neuroligin-
beta-neurexin interaction results in maturation of excitatory and inhibitory synapses, at
both the pre- and postsynapse [27].
Consistent with the specific roles for NL1 and NL2, NL1 overexpression increases the
number of excitatory but not inhibitory synapses, while overexpression of NL2 increase the
number of inhibitory but not excitatory synapses. Interestingly, these changes appear to be
dependent on activity, since pharmacological inhibition of NMDAR prevents the increase
in the number of excitatory synapses normally seen These results suggest that neuroligins
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do not simply form synapses, but also specify and validate the synapse type depending on
the presence of receptor activity [7].
In vivo experiments are less clear about the role of the different neuroligins in synaptoge-
nesis. One set of experiments showed that mice lacking all three neuroligin genes (mice
have three neuroligin genes compared to the five in humans) die shortly after birth due
to respiratory failure. Embryonic cultures of neurons from these knockouts have both
impaired inhibitory GABAergic transmission and excitatory glutamatergic transmission.
These mice had substantially reduced NR1 content at their glutamatergic synapses, de-
creased spontaneous IPSP and EPSP frequencies, and have reduced amplitudes of evoked
IPSP and EPSPs. In addition, the number of inhibitory synapses decrease while the num-
ber of excitatory synapses increase. However, the density of total synapses in the brainstem
remains constant. This suggests that neuroligins are not essential for synapse formation
(since synapse density remained constant), but are essential for normal synapse validation
and maturation. It is not clear which cell adhesion molecule(s) substitutes for neuroligin at
the knockout synapses to initiate synaptogenesis [54]. Another set of experiments, looking
specifically at NL1 knockout mice, showed that the presynaptic terminals of neurons from
these mice do not become stabilized, and have dynamic active zones with a limited number
of NT vesicles, characteristics of immature synapses. These researchers also took neural
cultures from normal mice and observed that if NL1 overexpression was induced on DIV
5, when the synapses were normally immature, then synaptic maturation occurred rapidly.
Specifically, the stability of the presynaptic active zone, recruitment of presynaptic scaffold-
ing proteins, size of the synaptic vesicle pool, and frequency of neurotransmitter release
increased in neurons that overexpressed NL1. This maturation was NMDAR activity-
dependent, since it was blocked by APV. Taken together, these results show that NL1
plays a role in synapse validation (specifically synapse stabilization) through an activity
dependent mechanism [56]. The mechanism by which NL1 strengthens presynapses is not
clear, but it appears to be a retrograde signal that involves both PSD-95 and neuroligin,
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and results in increased sensitivity of the presynapse to extracellular calcium, resulting in
a form of short-term plasticity [18].
In summary, the neuroligins play a role in initiating synapse formation, with NL2 function-
ing at inhibitory synapses while NL1 functions at excitatory synapses, and NL1 also func-
tions to validate and stabilize excitatory synapses in an activity-dependent manner.
3.3 ROLE OF SYNCAMS IN SYNAPTOGENESIS
While less research has been done on SynCAMs compared to other adhesion molecules,
these proteins appear to play a similar, but not redundant, role as neuroligins during
synaptogenesis. SynCAMs initiate synapse formation, since expression of SynCAMs in
non-neuronal cells followed by coculturing of these cells with neurons showed that they
participate in homophilic binding and initiate synaptogenesis [3]. Also, overexpression of
SynCAMs in neurons results in an increased number of synapses [16], as well as a substantial
increase in the frequency of spontaneous neurotransmitter release (a measure of presynaptic
strength). As previously mentioned, overexpression of NL1 shows the opposite result,
with an increased number of synapses but no increase in synapse maturation [44]. More
recent work suggests that SynCAMs may also specify synapse type during the formation
of connections, since SynCAMs initiate the formation of excitatory, but not inhibitory,
synapses [16].
Taken together, these results suggest a role of SynCAMs in both synapse initiation and
synapse maturation, specifically at excitatory synapses. Whether either of these processes
is activity- dependent is not known.
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3.4 GLUTAMATE RECEPTOR EXPRESSION DURING
DEVELOPMENT
During the activity-dependent validation process, neurotransmitter released from the presy-
napse provides an initial signal by acting on postsynaptic receptors. In the case of gluta-
matergic synapses, the composition of glutamate receptors is not constant during develop-
ment; there are changes both in the type of receptor expressed and the subunit composition
of these receptors. As previously mentioned, experiments studying the effects of glutamate
receptor activity on the validation process using pharmacological inhibition produced con-
flicting results. This could be due to other molecules at the synapse, but may also be due
to the type of receptor that the neurotransmitter is acting on. These changes in receptor
expression could therefore have important implications in development, because activity
through different receptors could potentially result in different developmental changes i.e.
activity through one receptor type results in stabilization while activity through another
results in refinement.
Immunocytochemical analysis found that, while both AMPARs and NMDARs are found
throughout the cortex and hippocampus, there is a dramatic increase in the expression of
AMPARs in the early stages of development (DIV 3 to DIV 10), while there was no change
in the NMDARs expression. In fact, the proportion of synapses expressing NMDARs
remained constant, at about 60 % of all synapses; the proportion of synapses expressing
AMPARs increased from about 67 calcium influx through NMDARs during the course
of development. It is hypothesized that NMDAR signaling early in development actually
blocks the recruitment of AMPARs to the synapse, while in the adult brain NMDAR
activity recruits AMPARs (this recruitment was described previously as the mechanism
behind LTP) [21].
The subunit composition of the receptors change during development as well. In the
forebrain and midbrain, the NMDARs switch from receptors containing the NR2B subunit
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to the NR2A subunit. It is believed that the association of scaffolding proteins, like SAP102
and PSD-95, with different NMDARs results in differences in downstream signaling [53].
AMPAR undergo similar changes in subunit type. Immunocytochemistry studies have
revealed consistent low levels of GluR2 and GluR4 compared to the other two AMPAR
subunits. GluR1 and GluR3 both show increased transcription between DIV 11 and DIV
17 before returning to a baseline level [43]. Taken together, these results suggest that
different glutamate receptor subunits are expressed at specific points during development,
and this differential expression may play a critical role in allowing for specific types of
postsynaptic responses at appropriate times during development.
3.5 GLUTAMATE RECEPTOR ACTIVITY AND SYNAPTIC
VALIDATION
This section will provide a brief review of some recent experiments attempting to deter-
mine the role of glutamate receptor activity on synaptic validation. Almost all research
in this area has focussed on the NMDARs rather than AMPARs because, as previously
described, the NMDAR is expressed early in development and AMPAR is brought into the
postsynaptic density as the synapse matures.
Several lines of research suggest that NMDAR activity plays a role in stabilizing synapses
during development. Retinal neurons that had all NMDAR activity blocked by the applica-
tion of D-APV beginning two hours after plating showed an increase in axonal branching
and an increase in the speed by which axons and dendrites reshape when compared to
control neurons. Interestingly, when APV was added 24 hours after plating, researchers
observed no changes in the morphology of the axon, but did still see an increased number of
dendritic branches. These results suggest that during development there is both activity-
independent and activity-dependent stabilization. Furthermore, during activity-dependent
47
process, NMDAR activity stabilizes both pre- and postsynaptic structures, and NMDAR
blockage results in the loss of this stability which leads to increased axon and dendrite
dynamics, including an increased in dendritic branching [41].
There are several proposed mechanisms for how NMDAR stabilizes newly formed synapses.
First, NMDAR activity can regulate the postsynaptic cytoskelton through the influx of
calcium, which slows the turnover of actin filaments. As previously mentioned, it is also
thought that NMDAR activation after the early stages of development recruits AMPARs
to the postsynapse, and this recruitment not only helps increase postsynaptic responses to
glutamate but also has been correlated with increased synapse size and density. Through
its calcium influx, NMDAR activation may also regulate the expression of other proteins,
like postsynaptic scaffolding molecules, that may promote maturation. Finally, activation
of NMDAR may increase the synthesis and release of trophic factors like BDNF, which
may be released into the synaptic cleft and act bidirectionally to validate formed synapses
[22].
There are, however, several experiments that suggest that NMDAR activation may instead
play a refining role during synapse validation. Luthi et al. took hippocampal slice cul-
tures and administered the NMDAR blockers APV and CPP for two weeks. They found
no change in postsynaptic currents, but an increase in the frequency of spontaneous neu-
rotransmitter release. They also found that these neurons had an increased density of
postsynaptic boutons, and an increase in the complexity of dendritic branching (dendritic
and axonal branching typically occurs at points near where stable synapses form). Taken
together, these results suggest that NMDAR activity refines newly formed synapses, which
also leads to a decrease in dendritic and axonal branching [30].
Another, more recent study used selective knockouts of the NR1 subunit, and found that
this deletion of NMDAR resulted in an increased number of functional synapse. This
increase is blocked by the reintroduction of the NR1 subunit to the neurons that were
NMDAR-deficient; this blockage is also dependent on NMDAR activity, since reintroduc-
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tion of NMDAR followed by D- APV application still results in an increased number of
functional synapses [1]. Additionally studies supporting the role of NMDAR in synaptic
refinement found that application of APV prevented normal neural retraction that occurs
during cerebellar development [40].
One final point to make is that, in this project, synaptic validation is assessed by synapse
size. Several studies have found a correlation between the size of synaptic contacts and
synaptic maturity and synaptic strength (measured by amplitude of spontaneous postsy-
naptic potentials) [51].
3.6 HETEROLOGOUS SYNAPSE SYSTEMS
The model system used in this project is called Heterologous Synapse Systems, but the
terms Hemisynapses or Mixed Culture Assay are also used in the literature. This section
will cover some of the important papers that have used the assay as an experimental
technique.
Scheiffele et al. were the first group to discover that non-neuronal cells expressing adhesion
proteins could form synapses with cocultured neurons. The group expressed both NL1 and
NL2 in HEK cells and stained cocultured neurons for synapsin. They found that synapsin
accumulates on axons that are in contact with NL-expressing HEK cells. They also found
that staining for synaptotagmin followed by neural stimulation resulted in the exocytosis of
vesicles at these heterologous synapses, indicating that the contacts are functional synapses.
The group went on to show that the synapses were formed by the interaction of neuroligin
and beta-neurexin, since addition of soluble beta-neurexin to the coculture or mutations
to the cholinesterase-like domain of neuroligin prevented formation of these heterologous
synapses [46].
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Functional heterologous synapse systems were subsequently developed by Fu et al. These
researchers transfected HEK cells with both NL1 and NMDAR (NR1 and NR2A or NR2B)
or AMPAR (GluR2) subunits, and they found that they could record postsynaptic sponta-
neous currents in their heterologous synapses. These currents were equal in both amplitude
and decay kinetics to neuron-neuron synapses, and the currents increased in frequency
when PSD-95 was introduced into the heterologous system (mirroring in vitro overex-
pression studies). These results support the posit that these heterologous synapses are
physiologically very similar to bona-fide neuron-neuron contacts [17].
Heterologous synapse systems were extended to include other adhesion molecules besides
neuroligins. Biederer et al. showed that if the full SynCAM protein was expressed in HEK
cells, and these HEK cells were cocultured with neurons, then fluorescent dyes could be
used to show that vesicle exocytosis was occurring at neuron-HEK contacts. Simultaneous
introduction of glutamate receptors with SynCAM also revealed spontaneous postsynaptic
currents similar to both neuron-neuron synapses and the heterologous synapses formed
by NL. These currents were blocked by the AMPAR antagonist CNQX as well. This
paper also showed that glutamate receptors alone were not sufficient to trigger presynaptic
vesicle clustering, and cocultures with HEK cells expressing only the receptors did not
show spontaneous postsynaptic currents [3].
Heterologous synapses can be initiated by neuroligins and SynCAMs, but not all adhesion
molecules can induce synapse formation in this assay; notable exceptions include the N-
Cadherins and SALMS [10].
The initiation of heterologous synapses is not restricted to postsynaptic adhesion molecules.
Nam and Chen expressed beta-neurexin in HEK cells and after coculture found PSD-95
clustering in dendrites of contacting neurons. They found that this result was specific
to beta-neurexin and not other presynaptic adhesion molecules like SynCAMs and N-
Cadherins, and that the synapses that were formed were primarily excitatory. Furthermore,
NMDARs were clustered at these glutamatergic synapses, and AMPARs were recruited to
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the contacts following glutamate application, similar to what would be expected following
activity at silent synapses (see LTP subsection in background) [35].
Recent work expressing NL2 instead of NL1 in COS cells and culturing these with neurons
have shown that NL2 clusters the alpha-neurexins at heterologous synapses, and that these
contacts are inhibitory, GABAergic contacts. The formation of inhibitory heterologous
synapses cannot be initiated by the neuroligins commonly found at excitatory synapses
(NL1, 3 or 4) or by scaffolding proteins found at excitatory synapses (PSD-95). These
results show that the heterologous synapse system is not specific to excitatory synapses,
but can form inhibitory synapses via a molecular mechanism that is consistent with both
in vitro and in vivo studies [12, 24].
While most heterologous synapse work is done in HEK cells for technical reasons (these
cells are easy to transfect, and do not require trypsin to be dissociated, which limits
possibility of trypsin- contamination in neural cultures), COS cells have the advantage of
having a large size, which provides a greater surface area for neural contact. Chubykin et
al. expressed neuroligins in COS cells and examined the heterologous synapses by labeling
the presynaptic terminals for beta- neurexin and using electron microscopy. The contacts
that were formed were uniform in size, and these contacts had functional presynaptic active
zones with docked vesicles. Interestingly, most but not all of the contacts had electron-rich
postsynaptic densities located on the non-neuronal cell [8].
There are certain instances where results from studies on heterologous synapses do not
mirror traditional in vitro or in vivo studies of neuron-neuron contacts. One example is the
comparison of heterologous synapses initiated by either NL1 or SynCAM. As previously
mentioned, overexpression studies suggest different roles for NL1 and SynCAM during
synaptogenesis; however, the electrophysiological data for heterologous synapses induced
by these proteins are by all accounts identical [44].
Because of the increased use of the heterologous synapse system, a standard protocol has
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been established, and was used for this project [4]. HEK cells were used in this experiment.
These are from an immortal cell line originally derived from human embryonic kidney.
There is some controversy surrounding the origin of these cells, since the kidney contains
several different cell types [48]. However, it is important to note that these cells do not
express neuronal cell adhesion molecules, receptors, or scaffolding proteins [47].
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4.0 SPECIFIC AIMS
The aim of this project is to use heterologous synapse systems to
1. Compare the effect of NMDAR and AMPAR activity on synaptic validation.
2. Compare the roles of NL and SynCAM on synaptic validation
3. Examine whether expression of NMDARs or AMPARs at different times in development
results in different effects on synaptic validation.
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5.0 MATERIALS AND METHODS
5.1 PLASMID PREPARATION
5.1.1 Plasmids
The following plasmids were obtained for use in this project:
Table 1: Table listing all plasmids used in this project, as well as their lab source
Plasmid Lab Source
pCAG-HA:NL1(ab) Peter Scheiffele
pCl-neo-GluR1::GFP Lu Chen
PCIS-NR1-2a:c-myc Anne Stephenson
pcDNA1-NR2A Jon Johnson
pCAG-SC1:FLAG Thomas Biederer
pLL3.7-GFP and pLL3.74-dsRed Luk Van Parijs
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5.1.2 Transformation
Transformation involves introducing the plasmids of interest into E.Coli bacteria in order to
prepare a greater amount of the plasmid DNA. The bacteria were incubated with the DNA,
and then heat shocked to create pores in the cell to allow the DNA to enter the cell. The
bacteria were then cultured overnight on media plates prepared with ampicillin; colonies
that were resistant to the antibiotic had successfully incorporated the plasmid.
All plasmids were transformed into Stbl3 E. Coli cells using the following protocol. Luria
Broth plates contained 100 ug/mL Ampicillin, and 25 mL of broth were in each plate.
1. Warm water bath to 42C
2. Thaw E. Coli (from -80) on wet ice
3. Add 5 ul of DNA, tap to mix
4. Incubate on ice for 30 min; place SOC media and Luria Broth plates in incubator
5. Heat shock bacteria for 45 s in water bath
6. Place on ice for 2 min
7. Add 250 ul SOC Media
8. Shake 1 h/ 37C/225 RPM
9. Plate 100 uL, incubate overnight
10. Store plates in fridge until use
5.1.3 Miniprep
A miniprep was performed in order to obtain small quantities of plasmid DNA from trans-
fected bacteria so that a restriction digest and gel electrophoresis could be performed in
order to confirm plasmid identity. Individual colonies were harvested and cultured in 3
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mL liquid Luria Broth with 100 ug/mL Ampicillin. This starter culture was shaken for 12
hours at 280 rpm, and then the cells were lysed and centrifuged, and the plasmid DNA
was collected from the appropriate layer.
1. Transfer 1 mL starter culture Eppe tube
2. Spin cells @ 6k/10min/4C. Remove supernatent
3. Resuspend pellet in 250 l Buffer P1 (Qiagen) and vortex
4. Add 250 l Buffer P2 (Qiagen), invert 4-6 times to mix. (Solution will turn blue).
5. Add 350 l Buffer N3 (Qiagen) and invert gently 4-6 times to mix. (Solution will turn
colorless).
6. Spin 13k rpm/10min/4min. White pellet will form.
7. Transfer supernatant to spin column.
8. Centrifuge 1min/13k. Discard flow-through.
9. Add 500ul Buffer PB(Qiagen), spin 1min/13k, discard flow-through
10. Add 750ul Buffer PE(Qiagen), spin 2x for 1 min/13k, discard flow-through
11. Transfer column to sterile 1.5 mL tube, add 25uL sterile DDW, let stand 1 min.
12. Spin 1min/13k to elute DNA.
13. Optical Density reading: 4 L DNA into 80 L Total. A260=[DNA]
5.1.4 Restriction Digests
Once purified DNA was obtained, 2 ug were digested by adding the appropriate restriction
enzymes and buffers. All digests were performed for 2 hours.
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Table 2: Table listing all restriction digest strategies for the plasmids used in this project
Plasmid Restriction Enzymes Number of Expected Bands
NL1 BamH1 and EcoR1 3
NR1 EcoR1 and XBa 2
NR2A HPa and NHE 4
GluR1 BamH1, XBa and NOT 4
pLL3.7-GFP and pLL3.74-dsRed HindIII 5
SynCAM EcoR1 2
5.1.5 Agarose Gel Electrophoresis
Agarose Gel Electrophoresis was performed on digested DNA in a 1.2 % gel by polymerizing
agarose in TAE buffer, loading 10 uL of each sample, and running a current through the
gel.
1. Pour 0.36 g of agarose into flask. Add 30mL TAE, boil for 25 seconds
2. Pour agarose/TAE with 1.5 uL EtBr into tray (with combs) when temperature is below
60C
3. Wait 20 min until gel settles
4. Take comb out, rotate gel, add the TAE until submerged
5. Add 2uL loading buffer per 10 uL sample or ladder
6. Load 10 uL of sample or ladder
7. Add 1.5 uL EtBr to both sides of gel
8. Run for 45 minutes at 115 V
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9. Visualize bands under UV light
5.1.6 Midiprep and Ethanol Precipitation
Once plasmid identity is verified, milligram quantities of DNA were prepared using a stan-
dard midiprep, and purified using ethanol precipitation. Larger starter cultures (100 mL
of media with 1000 uL of the miniprep starter culture) were initially prepared; the bacteria
were then lysed and centrifuged, and the DNA was collected. The DNA was then purified
from any protein contaminants by precipitating the plasmids out in ethanol.
1. Prepare midiculture:100 mL Luriabroth + 100 ug/mL Ampicillin + 1000 uL starter
culture
2. Shake overnight at 37 C, 225 RPM
3. Harvest cells: Centrifuge 15 min/4/4200 rpm.
4. Remove supernatent
5. Resuspend in 3 mL Cell Resuspension Solution from Qiagen Midiprep Kit
6. Add 3 mL Cell Lysis Solution from Qiagen Midiprep Kit, invert gently 5 times
7. Add 6 mL neutralization solution from Qiagen Midiprep Kit, invert gently 5 times,
incubate RT/ 10 min
8. Spin in ultracentrifuge with Vacuum at 4 C, 12000 RPM for 17 minutes
9. Pour supernatent into vacuum column with 10 mL resin from Qiagen Midiprep Kit,
apply
10. Flush with 15 mL of 40 % isopropanol/4.2 M guanidine HCl
11. Wash with 15 mL Column Wash Solution twice
12. Spin column collectant 2 min/max speed
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13. Move column to new tube, add 300 uL heated DDW, wait 2 min
14. Spin 2 min max to obtain DNA
15. Add 0.1X vol of 3 M pH 5.2 sodium acetate to samples, mix well
16. Incubate 5 min/0 C
17. Add 2.5 X vol cold 100 % ethanol, shake vigorously
18. Incubate 1 hour in freezer
19. Spin 15 min/max @ 4 C
20. Pipet out supernatent
21. Wash pellet with 1 mL ice cold 70 % ethanol
22. Aspirate out liquid, let pellet dry at 4C 1 hr
23. Resuspend in 200 uL RT DDW, leave overnight at 4C.
24. Dilute 4 uL DNA into 76 uL water, easure absorbance at 260 nm to obtain concentration
of DNA
25. Dilute to 0.5 ug/ul
26. Aliquot 50 ul tubes
5.1.7 Transfection
Once plasmid DNA was prepared, the following amounts of DNA was introduced into HEK
cells to create ten experimental groups.
HEK cells were transfected by adding a mixture of Lipofectamine reagent and plasmid
DNA to cells bathed in media without antibiotics, incubating the cells in this mixture for
three hours, and then the media was changed to remove the reagent from the cells.
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Table 3: Table showing the different experimental groups prepared for this project, as well
as the appropriate quantity of plasmid DNA transfected to create the groups.
Treatment Group DNA Amount DNA Amount DNA Amount
GFP 0.8 ug pLL3.7 X X
dsRed 0.8 ug pLL3.74 X X
NL 0.8 ug NL X X
NL/AMPAR 0.4 ug NL 0.4 ug GluR1 X
NL/NMDAR 0.4 ug NL 0.2 ug NR1 0.2 ug NR2A
AMPAR 0.8 ug GluR1 X X
NMDAR 0.4 ug NR1 0.4 ug NR2A X
SynCAM 0.8 ug SynCAM X X
SynCAM/AMPAR 0.4 ug SynCAM 0.4 ug GluR1 X
SynCAM/NMDAR 0.4 ug SynCAM 0.2 ug NR1 0.2 NR2A
1. Add 400 uL/well Lam/PLL solution (10 mL DDW, 7.8 uL Lam, 23.5 uL pLL); incubate
closed in hood overnight
2. Plate HEK cells at a density of 500,000 cells/mL for ICC using culture media (10 %
FBS, 1
3. Allow cells to grow to 90 % confluency
4. Replace media with Transfection Media (Culture Media without antibiotics)
5. Warm OptiMem to room temperature
6. Dilute Lipofectaime (2 uL) in Optim-mem (48 uL) per well. Mix gently, incubate RT
5 min
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7. Dilute DNA (0.8 ug total) in Opti-mem (50 uL total volume) per well
8. Add diluted DNA to diluted Lipofectamine
9. Mix gently, incubate 20 min RT
10. Add 100 uL to each well
11. Incubate 3 hours
12. Change media to prewarmed culture media
13. Coculture 24 hours later
5.1.8 Protein Harvest
After transfection, protein was harvested from the HEK cells in order to probe for the
successful introduction of the protein coded by the plasmid using Western Blots. Cells
were washed and then collected, centrifuged, resuspended in RIPA buffer, centrifuged, and
finally the protein layer was collected.
Table 4: Recipe for the preparation of RIPA buffer used in the protein harvest
Ingredient Concentration
Tris 20nM
NaCl 150 mM
EDTA 1 mM
Triton X-100 1%
DOC 0.5%
SDS 0.1%
PIC 1X
61
1. Place PBS in ice.
2. Label 1.5 mL eppe tube for each sample.
3. Make RIPA buffer (TX100 takes time to go into solution); keep on ice
4. Aspirate media, rinse 1X ice-cold PBS.
5. Add 1ml ice-cold PBS for scraping.
6. Scrape cells; transfer to 1.5 mL eppe tube.
7. Spin 3000rpm/5min/4C. (Loose pellet)
8. Carefully remove supernatant from pellet.
9. Add 50 uL RIPA buffer to each sample.
10. Pipet to mix/resuspend cells.
11. Spin 10 min/max/4C
12. Use 20uL pipet to remove 7uL + pellet (removing supernatent does not work- pulls
pellet)
13. Store at -80C.
5.1.9 Western Blots
After transfection, Western Blotting was performed in order to confirm successful intro-
duction of the protein coded for by the plasmid. The protein samples were run through a
PA gel to separate the proteins by size. The proteins were then transferred to a membrane,
and the membrane was then probed with antibodies for the presence of the target proteins.
The antibodies were conjugated with HRP, so they could be identified by adding substrate
and exposing the membrane to film.
1. Pour separating gel, overlay with water-saturated t-amyl alcohol.
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Table 5: Antibodies and dilutions used for Western Blots
Treatment Group Antibody Dilution
NL1 Chicken Anti-HA 1:100
NR1 Mouse Anti-cMyc 1:100 to 1:2000
NR2A Mouse Anti-NR2A 1:100 to 1:500
GluR1 Mouse Anti-GFP 1:100 to 1:1000
Table 6: Recipes for the solutions used for Western Blots
Solution Ingredients
10X Running Buffer 30.3 g Tris Base; 144.2 g Glycine; 10 g SDS; 1L Total
10X Transfer Buffer 30.3 g Tris Base; 144.2 g Glycine; 1 L Total
Blotting Buffer 25 mM Tris-Cl; 0.5 M NaCl; 0.5 % Tween 20
Blocking Solution 5% w/v instant nonfat dry milk in Blotting Buffer
Antibody Solution 2% w/v instant nonfat dry milk in Blotting Buffer
2. After gel hardens, rinse top with DDW 3X, carefully dry area above gel with paper
towel
3. Pour stacking gel, insert comb
4. While gel polymerizes, prepare protein samples (3 ug/uL); Denature 5 min at 95C
5. After gel hardens, remove comb, rinse wells with running buffer 3X, load into Hoefer,
overlay with running buffer
6. Load 10-15uL sample/well, 10uL Ladder
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7. Run 80V/gel; replenish running buffer periodically
8. Prepare Transfer buffer: 350mL DDW + 50ml 10X Transfer Buffer + 100ml MeOH
9. Prepare Transfer Case: Cathode, Plastic Grate, Sponge, Blotting Paper
10. Soak in Transfer Buffer
11. Cut gel to desired size, place blotting paper
12. Cut membrane to gel size
13. Prepare Membrane for transfer: MeOH (15sec) then DDW(2min) then rinse in transfer
buffer
14. Place membrane on gel
15. Complete Transfer Case: Blotting Paper, 2 sponges, plastic grate, anode
16. Transfer 85 min, 15V
17. Block in Blocking Solution RT/2hrs on rocker
18. Add 1 Ab diluted in Ab Solution, incubate RT/1hr on rocker
19. Wash 10min 5X in Blotting Buffer
20. Add 2 Ab diluted in Ab Solution, incubate RT/1hr on rocker
21. Wash 10min 5X in Blotting buffer
22. Add SuperSignal West Pico Stable Peroxide and Luminol mixed 1:1, incubate RT/5min
23. Thoroughly aspirate chemiluminescent substrate, cover membrane in cellophane, use
pipet to roll out excess substrate
24. Expose to film (start with 30s)
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5.1.10 Immunocytochemistry
Immunocytochemistry was used to confirm protein expression and membrane localization.
It was also used to stain heterologous synapse systems to determine the presynaptic mor-
phology.
The antibodies used are shown in Table 7, with the dilution in parenthesis.
Table 7: Antibodies with the appropriate dilutions that were used for ICC
Protein Target Primary Antibody Secondary Antibody
NL1 Chicken Anti-HA (1:25) Goat Anti-Chicken 555 (1:1000)
NR1 Mouse Anti-CMyc (1:1000) Goat Anti-Mouse 488 or 555 (1:1000)
NR2A Mouse Anti-NR2A (1:100) Goat Anti-Mouse 488 or 555 (1:1000)
SynCAM Rabbit Anti-FLAG (1:1000) Goat Anti-Rabbit 488 or 555 (1:1000)
Synapsin Rabbit Anti-Synapsin (1:500) Goat Anti-Rabbit 488 or 555(1:1000)
Table 8: Recipes for the solutions used for ICC
Solution Ingredients
PFA 3.8 mL DDW, 0.2 g PFA, 1X PBS, 25 uL 1 M
MgCl2, 100 uL 0.5 EDTA, 0.2 g sucrose
Permeabilization Solution 0.3% Triton X-100 in PBS
Block Solution 5% BSA in PBS
Antibody Solution 1% BSA in PBS
The cells were first fixed with 4% PFA, and then permeabilized with detergent (Triton
X-100). Nonspecific binding sites were then blocked with 5% BSA, and the cells were then
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incubated for one hour each with first primary and then secondary antibodies. The cells
were then placed onto microscope slides for visual analysis.
1. Prewarm fixative to 37C
2. Add 400uL/well prewarmed fixative to 24well dish
3. Transfer coverslip from media well to fixative well, incubate 10min
4. Appropriately discard fixative; wash PBS/5min/3X
5. Permeabilize with 500uL permeabilization solution
6. Wash PBS/5min/3X
7. Block in 500 uL blocking solution for one hour
8. Invert coverslip onto primary antibody beaded on flattened parafilm
9. Incubate 1hr
10. Return faceup to 24 well dish filled with PBS; Wash PBS 5min/3X
11. Invert coverslip onto secondary antibody beaded up on flattened parafilm
12. Incubate 1hr in dark
13. Return faceup to 24 well dish filled with PBS; Wash PBS/5min/3X
14. Submerge in Millipore water to remove PBS salts; dab excess water
15. Mount w/ 4ul Mounting Solution (Vectashied with DAPI)
16. Store 4C
5.1.11 Neural Culture
Because of IACUC restrictions, cortical neurons were harvested by other lab members from
embryonic mice at day E17 and plated at a density of 500,000 cells/mL on 24 well plates
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coated with laminin and poly-d-lysine using a standard protocol. Each well contained
500 uL, for a total of 250,000 cells/well. The media used consisted of Neurobasal, 2.5%
GlutaMAX, 20% B27, and 10
5.1.12 Coculture
Most HEK cells were transfected with the plasmid DNA as mentioned in the Transfection
Section six days after the neural harvest, and cocultured with neurons seven days after the
neuron harvest. For one set of heterologous synapses with HEK cells expressing either NL
or NL/NMDAR, the transfection occurred 11 days after neural harvest and the coculture
occurred 12 days after harvest.
For the cocultures, HEK cells expressing the appropriate proteins were split from their
original cultures and then plated onto neuronal cultures. Neuron culture media was used
for all steps, and Ara-C was added to prevent HEK cells from undergoing mitosis and
becoming overconfluent.
1. Equilibrate neuronal feeding medium (Neurobasal, 2.5 % GlutaMAX, 20 % B27 sup-
plement, and 10 %)
2. Prewarm HEK culture medium and Neurobasal
3. Aspirate medium from transfected FT cells without touching well bottom
4. Wash once with PBS
5. Pipet 100uL Trypsin into center of each well, forcibly enough to dislodge cells
6. Slap 24well dish several times to dislodge cells
7. Incubate 2min
8. While incubating, firepolish filtered Pasteur pipet
9. After incubation, add Pasteur pipet full of culture medium to each well
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10. Triturate transfected cells against bottom of each well until cells are separated (check
under scope)
11. Collect in 15ml conical tube
12. Centrifuge 1000rpm/5min
13. Aspirate supernatant, resuspend in 5 mL PBS (must remove all Trypsin)
14. Centrifuge 1000rpm/5min
15. Resuspend pellet in 3ml equilibrated Neurobasal
16. Dilute to 4x104 cells/ml (NOT 4x106 cels/ml!)
17. Remove 250ul medium from neuronal culture (24well dish)
18. Add 250ul of transfected FT cell suspension to neuronal culture
19. Add 2 uM Ara-C to prevent HEK expansion
20. Rock gently to evenly distribute FT cells
21. Fix and stain cells either 24 hours or 48 hours after Coculture
5.1.13 Microscopy and Image Analysis
Cells were examined for protein expression and localization using a standard fluorescent
microscope at 63X magnification.
Images of heterologous synapses were taken using a confocal microscope. The top and
bottom of the HEK cell were determined, and fifteen slices were taken through the stack
at 63X, with 1000V gain used consistently throughout all experimentation. Standard
excitation bands provided by Leica were used to detect the secondary antibodies.
Images were then analyzed using ImageJ. The image analysis was carried out as follows.
Images used in the explanation are from one representative heterologous synapse with the
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HEK cell expressing NL1 alone. First, the confocal image stack of the synapsin staining
was projected onto a single image with the maximum intensity at each pixel, as shown
in Figure 9. Then, the image was thresholded to a level of 75, as shown in Figure 10;
this level was chosen because it allowed for the visualization of individual contacts in the
brightest images, while still allowing the analysis of the dimmer images. The number of
pixels above threshold was then measured, and normalized to the cross-sectional area of the
HEK cell on which the heterologous synapse was formed. This normalized total synaptic
contact was then multiplied by 100 to obtain the variable that was analyzed- Percent of
Total Synaptic Contact Per Cell.
A one-way ANOVA was then performed in Excel to compare Percent of Total Synaptic
Contact Per Cell between treatment groups.
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Figure 9: Image showing the projection of a confocal stack onto a single image, using
maximum intensity. This heterologous synapse was formed on an HEK cell expressing
Neuroligin alone, and synapsin is shown in red.
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Figure 10: Image showing the thresholding of the previous image to a level of 75. This
heterologous synapse was formed on an HEK cell expressing Neuroligin alone, and synapsin
is shown in black.
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6.0 RESULTS
6.1 CONFIRMATION OF PLASMID IDENTITY
An image of the gel electrophoresis of digested plasmids is shown below in Figure 11. This
image shows the successful sequencing of all the plasmids based on the digestion strate-
gies listed in the Restriction Digests subsection. All plasmids were digested for 2 hours;
one plasmid, the pLL3.7-GFP, showed an incomplete digest using this duration; subse-
quent overnight digests followed by gel electrophoresis showed the appropriate fragment
lengths.
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Figure 11: Image showing the results from the gel electrophoresis of digests for plasmids
used. Digests were performed as discussed in the Methods section. From left to right,
the lanes on the top row are: ladder; NL cut, NL uncut; NR1 cut, NR1 uncut; NR2A
cut, NR2A uncut; GluR1 cut, GluR1 uncut; GFP cut, GFP uncut, and ladder. From
left to right, the lanes on the bottom row are: ladder, dsRed cut, dsRed uncut; SynCAM
cut, SynCAM uncut. Aside from the GFP band, which shows incomplete digestion, the
bands are as expected, confirming the identity of the plasmids. The GFP was successfully
sequenced following a longer, overnight digest.
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6.2 HEK TREATMENT GROUPS
This section contains representative ICC images for successfully transfected HEK cells,
which confirm the appropriate expression and membrane localization of the neuronal pro-
teins that were introduced into the HEK cells.
Cells that express GFP, dsRed, NL, NL/GluR1, NL/NR1/NR2A, NR1/NR2A, GluR1,
SynCAM, SynCAM/AMPAR, SynCAM/NL, and non-transfected HEK cells are shown.
The image numbers, as well as the protein identified by fluorescent tag, are organized in
the table below.
Table 9: Legend for the representative images displayed below that confirm successful
transfection of HEK cells
Treatment Group Green Red Blue Figure Number
GFP GFP DAPI 12a
dsRed dsRed 12b
NL Anti-HA DAPI 13a
NL/AMPAR GluR1::GFP Anti-HA DAPI 13b
NL/NMDAR Anti-NR2A Anti-HA DAPI 13c
NMDAR X Anti-cMyc DAPI 14a
AMPAR GluR1::GFP DAPI 14b
SynCAM Anti-FLGA DAPI 15a
SynCAM/AMPAR GluR1::GFP Anti-FLAG DAPI 15b
SynCAM/NL Anti-FLAG Anti-HA DAPI 15c
Control HEKs Anti-NR2A/cMyc/FLAG Anti-HA DAPI 16
In order to ensure that non-transfected HEK cells do not express the neuronal proteins of
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(a) HEK cell expressing GFP (b) HEK cell expressing dsRed
Figure 12: HEK cell transfected with either GFP (a) or dsRed (b). Nuclei are labeled blue
with DAPI. Image magnification is at 63X.
interest in this project, standard HEK cells were probed using the appropriate antibodies
for NL, NR1, NR2A, and SynCAM. The result of this experiment is shown below in Figure
16.
One problem with the use of the GFP in HEK cells is that the excitation band of this
protein was so broad that was excited by both the red and the green channel, producing a
phenomenon where the GFP would ”bleed” into the red channel. This is shown below in
Figure 17.
In addition to the ICC results shown above, Western Blotting was attempted in order to try
and confirm proper protein expression after transfection. Only the NL blot was successful-
this is shown below in Figure 18.
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(a) HEK cell expressing NL (b) HEK cell expressing NL and AMPAR
(c) HEK cell expressing NL and NMDAR
Figure 13: Representative image of HEK cells transfected with either NL, NL/AMPAR,
or NL/NMDAR. NL is immuolabeled for the HA epitope (red) in (a), (b), and (c).
GluR1::GFP is shown in green in (b). NR2A is immunolabeled green in (c).
All cells that expressed GluR1 or NR2A also expressed NL, but not all cells that expressed
NL also expressed the receptor subunits (data not shown). Nuclei are labeled blue with
DAPI. Image magnification is at 63X.
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(a) HEK cell expressing NMDAR (b) HEK cell expressing AMPAR
Figure 14: Representative images of HEK cells transfected with either NMDAR alone (a)
or AMPAR alone (b). NR1 is immunolabeled red in (a).GluR1::GFP is shown in green in
(b). Nuclei are labeled blue with DAPI. Image magnification is at 63X.
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(a) HEK cell expressing SynCAM (b) HEK cell expressing SynCAM and AMPAR
(c) HEK cell expressing SynCAM and NL
Figure 15: Representative images of HEK cells transfected with either SynCAM (a), Syn-
CAM/AMPAR (b), or SynCAM/NL (c). NL is immuolabeled for the HA epitope (red)
in (c). GluR1::GFP is shown in green in (b). SynCAM is immunolabeled for the FLAG
epitope (green in (a) and (c), red in (b)). Nuclei are labeled blue with DAPI. Image
magnification is at 63X.
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Figure 16: Image showing a nontransfected HEK cell probed for NL, NR1, NR2A, and
SynCAM. Both the green and red channels are overlayed, and nuclei are labeled with
DAPI (blue). Image is at 63X magnification
Figure 17: Image showing GFP bleeding into red channel. This is an HEK cell transfected
with only GFP. The GFP is excited by both the green and the red channel, even though no
protein fluorescing red is present in the cell. The response by the GFP to both channels is
in green and red, and nuclei are labeled with DAPI (blue). Image is at 63X magnification
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Figure 18: Image showing the Western Blot of an HEK cell transfected with NL
6.3 COCULTURE IMAGES
This section contains representative images for succesful cocultures between transfected
HEK cells and neurons. These images confirm the effective formation of heterologous
synapses between the neurons and HEK cells. Cocultures between neurons and HEK cells
that express GFP, dsRed, NL, NL/AMPAR, NL/NMDAR, AMPAR, SynCAM/AMPAR,
and SynCAM/Nl are shown below. The image numbers, as well as the protein identified
by the appropriate fluorescent tag, are organized in the table below.
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Table 10: Legend for the representative images shown below that confirm successful cocul-
ture between the HEK cells and neurons.
Treatment Group Green Red Figure Number
GFP GFP Anti-Synapsin 19a
dsRed Anti-Synapsin dsRed 19b
NL Anti-Synapsin Anti-HA 20a
NL/AMPAR GluR1::GFP Anti-Synapsin 20b
NL/NMDAR Anti-NR2A Anti-Synapsin 20d
NMDAR Anti-Synapsin Anti-NR2A 21a
AMPAR GluR1::GFP Anti-Synapsin 21b
SynCAM/AMPAR GluR1::GFP Anti-Synapsin 22a
SynCAM/NL Anti-Synapsin Anti-HA 22b
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(a) Coculture between neuron and HEK cell ex-
pressing GFP
(b) Coculture between neuron and HEK cell ex-
pressing dsRed
Figure 19: Representative image of a coculture between neuron and HEK cell expressing
either GFP (a) or dsRed (b). GFP is green (a), and dsRed is red (b). Synapsin is immuno-
labeled red (a) or green (b). All HEK cells were transfected on DIV 6 and cocultured DIV
7. Image magnification is at 63X.
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(a) Coculture between neuron and HEK cell ex-
pressing NL
(b) Coculture between neuron and HEK cell ex-
pressing NL and AMPAR
(c) Coculture between neuron and HEK cell ex-
pressing NL and NMDAR, stained for NR2a
(d) Coculture between neuron and HEK cell ex-
pressing NL and NMDAR, stained for synapsin
Figure 20: Representative image of a coculture between neuron and HEK cell expressing
either NL (a), NL/ AMPAR (b), or NL/NMDAR (c and d). In (a), NL is immunolabeled
for the HA epitope in red and synapsin is immunolabeled green. In (b), GluR::GFP is
shown in green, and synapsin is immunolabeled in red. In (c), NR2A is immunolabeled
green, while in (d) synapsin is immunolabeled red and the site of the HEK cells are circled.
Figures (c) and (d) were separated because the NR2a antibody was too dim to be seen
on an overlay. All HEK cells were transfected on DIV 6 and cocultured DIV 7. Image
magnification is at 63X.
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(a) Coculture between neuron and HEK cell ex-
pressing NMDAR
(b) Coculture between neuron and HEK cell ex-
pressing AMPAR
Figure 21: Representative image of a coculture between neuron and HEK cell expressing
either NMDAR alone (a) or AMPAR alone (b). In (a), NR2A is immunolabeled red and
synapsin is immunolabeled green. In (b), GluR1::GFP is shown in green, and synapsin
is immunolabeled red. All HEK cells were transfected on DIV 6 and cocultured DIV 7.
Image magnification is at 63X.
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(a) Coculture between neuron and HEK cell ex-
pressing SynCAM and AMPAR
(b) Coculture between neuron and HEK cell ex-
pressing SynCAM and NL
Figure 22: Representative image of a couclutre between neuron and HEK cells expressing
either SynCAM/ AMPAR (a) or SynCAM/NL (b). In (a) GluR1::GFP is shown in red,
and synapsin is immunolabeled green. In (b) NL is immunolabeled for the HA epitope
(red), and synapsin is immunolabeled green. All HEK cells were transfected on DIV 6 and
cocultured DIV 7. Image magnification is at 63X.
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6.4 COCULTURE RESULTS
For all coculture images, the presynaptic area was determined by taking the stacks of images
of heterologous synapses stained for synapsin, compressing the stacks into one image with
the maximum intensity at each pixel, thresholding all images, then determining the area
of the synapsin staining above threshold in pixels. This area was then normalized to the
area of the cross-sectional HEK cell for each heterologous synapse. The complete details
of this technique, as well as figures diagramming the procedure, are shown in the Methods
section.
Some samples were fixed and stained one day after coculture and others two days after
coculture. When controlling for treatment groups, no statistically significant difference
in presynaptic area was found between these two timepoints. These results are shown in
Table 13.
Heterologous synapses between neurons and HEK cells expressing NL and either gluta-
mate receptor were, on average, smaller than heterologous synapses where the HEK cells
expressed NL alone. This difference was statistically significant when the two glutamate
receptors were combined as one treatment group (p < 0.05), and when the NL treatment
group was compared to the NL/AMPAR treatment group (p < 0.01) but not when the NL
treatment group was compared to the NL/NMDAR treatment group (p = 0.14).
Heterologous synapses between neurons and HEK cells expressing SynCAM and AMPAR
were, on average, much larger than those where HEK cells expressed NL and AMPAR, but
the sample size was not large enough to achieve statistical significance.
Finally, a comparison of presynaptic size in HEK cells expressing NL/NMDAR that were
cocultured 12 days after neural harvest compared to 7 days after harvest shows that synapse
size is larger in those heterologous synapses cocultured later, and this difference is statis-
tically significant. These results are summarized in Table 13.
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A table showing each treatment, with number of cocultures, average presynaptic size and
standard deviation, and the results of the T-Test comparing the various treatment groups
to the NL group is shown below in Table 11. In this table, SC is an abbreviation for
SynCAM.
A table specifically comparing the heterologous synapses for HEK cells expressing NL/AMPAR
and those expressing SynCAM/AMPAR is shown in Table 12.
Table 11: Summary of Results
Treatment Group NL NL/AMPAR NL/NMDAR SC/AMPAR SC/ NL
Number of Cells 26 6 8 3 2
Average Total
Synaptic Area, %
65 45 51 67 19
Standard Deviation 33 10 20 56 1.0
P-Value (compared
to NL)
0.01 0.14 0.64
Table 12: Neuroligin vs SynCAM Results
Treatment Group NL/AMPAR SynCAM/AMPAR
Number of Cells 6 3
Average Total Synaptic Area, % 45 84
Standard Deviation 10 60
P-Value 0.38
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Table 13: Comparison of Timepoint Results
Treatment Group NL/NMDAR, DIV 7 NL/NMDAR, DIV 12
Number of Cells 4 4
Average Total Synaptic Area, % 64 39
Standard Deviation 14 13
P-Value 0.02
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7.0 DISCUSSION AND FUTURE DIRECTIONS
7.1 EXPRESSION OF NEURONAL PROTEINS BY HEK CELLS
The digest of plasmid DNA followed by gel electrophoresis and sequencing was an important
first step in this project. None of the plasmids were manufactured in our lab, and all had
their sequences confirmed by the research groups that created them. However, at every
stage of the purification process there is the potential for contamination. As seen in Figure
11, the gel shows the expected bands for the desired plasmids.
The plasmids were then transfected into HEK cells to create the various experimental
groups. Originally, calcium phosphate transfection was used to introduce the DNA. How-
ever, this had a poor transfection efficiency. Since the possibility of heterologous synapse
formation depends not only on the density of HEK cells and neurons in the culture, but
also on the successful expression of neuronal proteins by the HEK cell, Lipofectamine
transfection was utilized throughout the remainder of the project.
Initially, Western Blotting was used to confirm protein identification. However, only blots
probing for NL were successful. Blots probing for all other proteins showed a blank film
with nothing labeled. Some of the possible explanations are described below.
First, the NR2A subunit has a large molecular weight (180 kDa, compared to 115 kDa
for NL). This could result in problems during the transfer of the protein from the gel to
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the membrane. Because the process involves placing the membrane over the gel and then
applying a voltage to pull the protein out of the gel, larger proteins move more slowly,
and some may not be able to move through the pores during the transfer time. To see
whether this was the issue, two different parameters were varied. First, the voltage applied
during the transfer was increased from 15V to 30V in order to see whether providing an
increased electrostatic force could pull the larger proteins through without denaturing.
Second, the duration of the transfer was increased from 75 minutes to 120 minutes in
order to see whether a longer application of the voltage could pull the larger proteins onto
the membrane without also pulling smaller proteins off of the membrane and into solution.
Neither of these adapted transfer processes resulted in successful probing for the transfected
proteins.
The second potential reason for why the Western Blots were not successful may be because,
as mentioned in the Methods Section, several of the proteins were probed using epitope
markers. These are short peptide fragments that are artificially introduced into the protein
by adding the appropriate nucleotides to the gene sequence (similar to fluorescent tags).
They do not alter protein function, but can be used to identify transfected, and not en-
dogenous, proteins. It was important to use epitope tagging in this project because all
the proteins that were introduced into the HEK cells are already expressed by neurons. If
cocultures were stained simply for the neuronal proteins, it would be difficult to separate
the immunocytochemical staining of transfected protein from the neuronal protein, and
this would complicate the image analysis of the heterologous synapses. Using epitope tags
avoids this issue. The issue with using these tags is that they are designed to be identified
using immunocytochemical detection. It is possible that while running the gel to sepa-
rate proteins, or during the transfer process, the tag is made unavailable for detection by
antibodies.
Despite the issues with using Western Blots to confirm protein expression, immunocy-
tochemistry shows that these plasmids were successfully transfected into the HEK cells.
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These images also showed that the proteins were primarily localized to the membrane. This
is an important criterion, since the heterologous synapses occur between the axon and the
membrane of the HEK cell, and so the proteins have to be located on the cell surface in
order to interact with the contacting neuron.
All treatment groups had some HEK cells that expressed the plasmids, but the expression
efficiency was not consistent between the different proteins. Qualitatively, the same number
of cells were successfully transfected with GFP, dsRed, NL, or NR. However, relatively
fewer cells transfected with GluR1 or NR2A expressed these proteins. This could be due
to a variety of issues, including the efficiency by which the plasmid is introduced into the
cell, or the ability of the cell to transcribe the plasmid. This limitation was overcome by
identifying transfected cells by the presence of GluR1 or NR2A, since for the NL/AMPAR
and NL/NMDAR treatment groups, all cells that expressed NL also expressed GluR1 or
NR2A, but not all cells that expressed GluR1 or NR2A also expressed NL.
One final point to note about the transfection of the various treatment groups is the HEK
cells expressing GFP show bright fluorescence under both the red and green channels of
the microscope. This causes problems when these cells are cocultured with neurons, since
it is difficult to differentiate whether the red is from the GFP or from the labeled synapsin
protein on the neurons. Since the intensity of fluorescence was relatively equal through
both the green and the red channel, this was overcome by subtracting the green channel
intensity from the red channel intensity when analyzing the cocultures for synapsin area.
Images of the red channel of a coculture before and after this subtraction are shown below
in Figures 23 and 24.
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Figure 23: Image showing the successful coculture of a neuron with an HEK cell expressing
GFP. Synapsin is labeled red, but there is bleedthrough from the green into the red channel.
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Figure 24: Image showing the subtraction of the green channel from the red channel.
Synapsin is shown in green.
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7.2 DISCUSSION OF COCULTURE RESULTS
In this project, the presynaptic size in heterologous synapses was measured by staining
the contacting axons for VAMP, synaptotagmin, and synapsin. However, the antibodies
for VAMP and synaptotagmin did not prove to be as successful as synapsin in producing
individual puncta at synaptic sites. The antibody against VAMP, even at a dilution of
1:100, did not label synapses brightly enough. The synaptotagmin antibody, even at a
dilution of 1:2000, lit up the entire neuronal process extremely brightly, as seen in Figure
25. For this reason, all analysis focussed on synapsin staining. Future work should also try
to correlate the synapsin results with stainings for other presynaptic proteins.
It is important to note that the results from this analysis are complicated by three factors.
First, there is inherent randomness to the formation of heterologous synapses. Since the
cultures are not controlled, neurons can grow their processes in any direction, and so they
may miss coming into contact with cocultured HEK cells. The HEK cells that the neurons
do come into contact with also need to be expressing the appropriate postsynaptic proteins,
and because of the poor expression of GluR1 and NR2A, neurons formed more heterologous
synapses with HEK cells expressing NL alone than NL/AMPAR and NL/NMDAR. When
the HEK cells are seeded on neurons in a 24 well dish, a single well typically yields anywhere
from 0 to 5 heterologous contacts. Finally, the antibody used to stain SynCAM was
developed in a rabbit host, the same as synapsin. Because of this, it was not possible
to do immunocytochemical analysis on heterologous synapses with HEK cells expressing
SynCAM alone.
There was no accumulation of synapsin in contacting axons of neurons cocultured with
HEK cells expressing GFP, dsRed, NMDAR, or AMPAR. This is expected, since HEK
cells do not, on their own, express the adhesion molecules that are necessary to initiate
synapse formation. The expression of the glutamate receptors alone also is not sufficient
to cause synaptogenesis to occur. There are some interesting qualitative observations from
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Figure 25: Image showing a neuron culture stained for synaptotagmin and neuroligin. The
important thing to note is that the synaptotagmin staining lights up the entire process
brightly, even after diluting the primary antibody by 1:2000. This makes it difficult to
identify individual sites of synaptic contact.
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images of these cocultures. First, it was difficult to determine the difference between
synapsin in contacting axons and GFP in HEK cells because of excitation of GFP by the
red channel, which made it difficult to differentiate red fluorescent proteins from green
fluorescent proteins in cocultures. For this reason, the expression of a red fluorescent
protein served as the primary control. In the image of this coculture (Figure 26), some
points of contact between the axon and the HEK cell can be seen. These contacts do not
disappear when the image is thresholded (Figure 27), but the areas are much smaller than
the sites of contact formed with HEK cells expressing NL. It can be hypothesized that
the axon recognizes the surface as the HEK cell as a potential site for synaptogenesis, but
does not initiate synapse formation and synapsin localization because the appropriate cell
adhesion molecules are not present.
The analysis of the amount of synapsin staining in contacting axons shows a trend where the
expression of glutamate receptors results in a smaller presynaptic area than in heterologous
synapses expressing NL alone. This difference was statistically significant between the NL
and the NL/AMPAR treatment groups, but not for the NL and the NL/NMDAR treatment
groups.
It is also interesting to note that in all cases, the postsynaptic proteins that were transfected
into the HEK cell did not target to the heterologous synapse, but instead remained localized
around the entire membrane of the cell. As mentioned in the Theory Section, NMDAR
and AMPAR targeting to the synapse is mediated by other postsynaptic proteins, like
PSD-95, NARP, Syndecan, and the EphB Receptor. Since these proteins are absent in the
HEK cells, it is not unusual to expect that these proteins are not localized to the neuron
contact. The targeting of NL1 is slightly more complicated, since it is hypothesized that
PSD-95 is involved in the recruitment of these proteins to the synapse, but mutations to
the PDZ domain on PSD-95 that binds to NL do not result in alterations in its synaptic
targeting. Future work may involve introducing NARP, Syndecan, or the EphB receptors
into HEK cells and examining whether the NMDAR and AMPAR are then localized to the
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Figure 26: Image showing the successful coculture of a neuron with an HEK cell expressing
dsRed. dsRed is red, and synapsin is labeled green. Arrows label sites of potential contact
Image is from a confocal micrscope at 40X magnification
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Figure 27: Image showing the successful coculture of a neuron with an HEK cell expressing
dsRed, after threshold. Black indicates synapsin. Arrows label sites of potential contact,
and the location of the original HEK cell is circled in green. Image is from a confocal
micrscope at 40X magnification
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synapse. It may also prove interesting to see whether the localization of these receptors to
the synapse results in any changes in synapse validation, since the glutamate receptors are
now directly opposed to the presynaptic release machinery. This system can also be used
as an assay to screen proteins that are potentially involved in synaptic targeting of NL1
by introducing candidate proteins into the HEK cell and examining heterologous synapses
for NL1 targeting.
Because of the prevalence of NMDAR at early synapses, few experiments have examined
the role of AMPAR activity on activity-dependent validation. The results of this project
suggest that AMPAR activity serves to refine initial synaptic contacts. The trend in
heterologous synapse size between the NL treatment group and the NL/NMDAR treat-
ment group are consistent with the results produced by Luthi et al [30], which found that
long-term administration of NMDAR blocker resulted in an increased density of synaptic
contacts. The absence of NMDAR expression can mirror long-term pharmacological inhi-
bition, since the receptors are not present at the postsynapse to decipher neurotransmitter
release. These results support the hypothesis that NMDAR activation results in synaptic
refinement.
Other studies have found evidence supporting the view that glutamate receptor activity
results in synaptic stabilization. In particular, calcium influx through the NMDAR is
thought to stabilize synapses by regulating the cytosekelton, recruiting AMPAR, regulating
gene expression, and increasing the synthesis of trophic factors. Furthermore, experiments
on the role of NL in validating initial excitatory contacts was found to be dependent on
NMDAR activity. It could be that other postsynaptic proteins could be contributing to
produce this net effect. In particular, PSD-95 has been found to be a critical role in the
validation of excitatory synapses. The absence of PSD-95 (and the other postsynaptic
proteins that this scaffolding molecule complexes at the synapse) in these heterologous
synapses could be one reason for the discrepancy between the results of this project and
the other experiments studying excitatory synapse validation.
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Several experiments have found a role for NL1 in validating excitatory synapses in a manner
that is dependent on NMDAR activation. The results of this project do not reflect this
hypothesis, since the NL/NMDAR treatment group had heterologous synapses that were
smaller than the NL treatment group (though the number of replicates did not allow these
results to achieve statistical significance). These experiments can be reconciled with the
results of this project by recognizing that in heterologous synapses, nearly all postsynaptic
constituents are absent. It is possible that the stabilization of newly formed synapses
requires calcium influx through the NMDAR that then acts upon another protein (e.g.
Protein Kinase C, or CaMKII) which is not present in this system. In this sense, NMDAR
activation alone is not sufficient to trigger the stabilization that is seen in these other
experiments.
Because of the differential expression of glutamate receptors during development, it is pos-
sible that more mature neurons may be responding differently to the retrograde signal
from the postsynapse that result from NMDAR activation. This hypothesis was tested by
coculturing neurons at a later time point (DIV 12 compared to DIV 7) and then comparing
presynaptic size within a treatment group. There was only enough time to complete exper-
imental groups containing NL/NMDAR. An analysis of the synapsin staining shows that
cocultures with more mature neurons resulted in smaller heterologous synapses, and that
this difference was statistically significant. This result suggests that as neurons become
more developmentally mature, they respond differently to retrograde signals resulting from
postsynaptic NMDAR activity; NMDAR activity seems to play a greater role in refinement
in older cultures. Successful cocultures for NL and NL/AMPAR are needed at DIV 12 in
order to examine how the absence of glutamate activity, and how AMPAR activity, changes
as neurons mature.
A comparison of heterologous synapses between neurons and HEK cells expressing NL
and HEK cells expressing SynCAM is limited here because of the small number of data
points, and the lack of successful heterologous synapses between neurons and HEK cells
100
expressing SynCAM/ NMDAR. The average presynaptic area is larger in cells express-
ing SynCAM/AMPAR compared to NL/AMPAR, but the error, particularly in the Syn-
CAM/AMPAR group, is almost as large as the average value and the results are not
statistically significant. More cocultures with HEK cells expressing SynCAM/AMPAR
and SynCAM/NMDAR need to be performed before any conclusions can be drawn. In-
terestingly, a comparision of heterologous synapses between HEK cells with NL and HEK
cells with NL/SynCAM show that NL/SynCAM has a much smaller presynaptic size, with
a very low p-value (p< 0.001). However, this is most likely due to the small deviation in
presynaptic size in the NL/SynCAM treatment group, and the small number of synapses
found in this group (n = 2) suggests that more experiments need to be performed to identify
a greater number of heterologous synapses before a conclusion can be drawn.
It is important to emphasize that heterologous synapses are an inherently simplified sys-
tem. Because many aspects of the postsynapse, including different proteins, dendritic
outgrowth, and cytoskeletal structures, are absent in this technique, the results of this
project needs to be used in conjunction with bona-fide neuron-neuron experimentation in
order to understand the molecular dynamics of synaptogenesis.
7.3 FUTURE DIRECTIONS
The next step in this project is to obtain heterologous synapses from the remaining experi-
mental groups. This would include more data points for the SynCAM, SynCAM/AMPAR
and SynCAM/NL treatments, in order to determine the activity-dependence of synaptic
validatino by SynCAM. In order to study the time course of development, cocultures with
mature neurons at DIV 12 and HEK cells expressing NL and NL/AMPAR will be obtained
as well. If significant differences in the size of heterologous synapses between these time
points are found, more thorough time courses can be obtained.
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The inherent randomness of heterologous synapse formation was discussed in the last sec-
tion. One future direction for this project could then be to coculture neurons and HEK
cells in a microfluidic device that guides axon outgrowth from the neuron to the trans-
fected HEK cell. This could be accomplished by culturing the neurons in one chamber and
the HEK cells in another. Strips between the two chambers could then be coated with
molecules like laminin and poly-D- lysine to promote axonal outgrowth. This directed out-
growth would result in a greater number of heterologous synapses for a given experimental
group.
It would also be useful to introduce more proteins into the HEK cell in order to study how
postsynaptic interactions affect synaptic validation. For example, the scaffolding proteins
PSD-95 and Stargazin can be included along with NL and the glutamate receptors to see
how complexing the receptors to the cell adhesion molecule affects synaptic development.
Other postsynaptic proteins involved in synaptogenesis, like CaMKII, could also be intro-
duced. It would also be interesting to introduce NL and both NMDAR and AMPAR into
the same HEK cell, and see how combined expression of two different glutamate receptors
affects synaptic validation. It may also prove useful to introduce the proteins involved in
glutamate receptor targeting at the synapse (e.g. Syndecan, NARP, or EphB Receptor) to
see what effects these proteins have individually and collectively on not only targeting but
also synaptic validation.
The limitation with the techniques of this project is that Lipofectamine transfection is only
capable of introducing up to three plasmids into a cell. Other gene delivery techniques, like
Lentivirus delivery, would have to be used to pursue these other types of experiment.
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